Clinical Deep Dives

making mental health inseparable from metabolic health.

Episode Description

Medlock Holmes enters The Metabolic Control Room, an immense Neo-Victorian chamber built around a glowing bloodstream. At its centre sits a vast brass dial labelled GLUCOSE, connected to the pancreas, brain, heart, kidneys, eyes and peripheral nerves.

At first, the machinery seems straightforward.

In type 1 diabetes, autoimmune destruction of pancreatic β cells leaves the body producing little or no insulin.

In type 2 diabetes, insulin resistance dominates initially, often followed over time by declining insulin production.

But Holmes soon discovers that controlling diabetes requires something no machine can supply automatically: continuous human self-management. The chapter describes diabetes as an unusually complex chronic illness in which successful outcomes depend heavily on the patient’s own behaviour and supportive relationships.

Every day brings decisions about:

MEDICATION • FOOD • EXERCISE • GLUCOSE MONITORING • SMOKING • APPOINTMENTS • COMPLICATIONS

Then Holmes notices another mechanism connected directly to the glucose dial.

It is labelled:

DEPRESSION

When depression enters the system, energy falls. Motivation weakens. Concentration becomes harder. Exercise decreases. Diet may deteriorate. Prescriptions are missed. Appointments become harder to attend. Diabetes begins to feel impossible to control.

Worsening diabetes then creates more symptoms, complications, restrictions and distress.

The machine forms a loop:

DIABETES → BURDEN → DEPRESSION → POORER SELF-MANAGEMENT → WORSE DIABETES

But the relationship is not merely behavioural.

Hyperglycaemia, inflammation, vascular changes, stress systems and neuronal insulin signalling may contribute to the biological connection between diabetes and depression. The direction of causality therefore cannot simply be reduced to “the patient is depressed because they have diabetes.”

Holmes finds another clue.

Depression can change not only the disease but the experience of the disease.

A patient with depression may report substantially greater fatigue, pain and other diabetes-related symptoms even when objective measures such as HbA1c do not fully explain the difference.

This creates an important psychiatric distinction:

DISEASE BURDEN ≠ EXPERIENCED SYMPTOM BURDEN

Then comes anxiety.

Sweating. Trembling. Palpitations. Dizziness. Fear.

Is this:

ANXIETY?

or

HYPOGLYCAEMIA?

For someone using insulin, the distinction can become frighteningly difficult. Repeated false alarms may encourage catastrophising; repeated genuine hypoglycaemia may eventually lead someone to dismiss symptoms that require urgent action.

Holmes next enters the Family Chamber.

A young child with type 1 diabetes cannot independently manage repeated glucose checks, insulin, food and exercise. Parents become part of the treatment system.

But adolescence changes the equation.

The developmental drive towards independence can collide directly with parental anxiety and the demands of diabetes:

“CHECK YOUR GLUCOSE.”

“TAKE YOUR INSULIN.”

“WATCH WHAT YOU EAT.”

What appears medically as non-adherence may sometimes represent a developmental struggle over autonomy, identity and control.

Another corridor contains the eating disorders.

Here Holmes discovers an especially dangerous possibility in insulin-dependent diabetes: deliberately reducing or withholding insulin to influence weight.

Further along lies another interconnected triangle:

DEPRESSION ↔ OBESITY ↔ TYPE 2 DIABETES

Shared behavioural, metabolic, inflammatory and neuroendocrine pathways make the relationship far more complex than a simple linear chain.

Then Holmes enters the psychiatric pharmacy.

The detective suddenly realises psychiatry itself can alter the metabolic machinery.

Some antipsychotics produce substantial weight gain and increase metabolic risk. Other psychotropic medications can also contribute to weight gain.

So psychiatric treatment must ask not only:

“Is this medication helping the mind?”

but also:

“What is it doing to the body?”

Finally Holmes reaches the most important room: Collaborative Care.

There is no separate psychiatric machine and diabetes machine.

One team monitors:

A1c • BLOOD PRESSURE • CHOLESTEROL • DEPRESSION

while simultaneously addressing medication, diet, exercise, smoking, motivation and problem solving.

The mystery is solved.

Diabetes and psychiatric illness do not merely coexist.

They can alter one another through:

BIOLOGY ↔ BEHAVIOUR ↔ EMOTION ↔ RELATIONSHIPS ↔ HEALTHCARE

And therefore the most useful clinical question is not:

“Which problem should we treat first?”

It is:

“HOW DO WE TREAT THE PERSON AND THE SYSTEM CONNECTING BOTH?”

Key Takeaways

1. Diabetes Is an Exceptionally Self-Managed Chronic Disease

Successful management depends heavily upon repeated behaviours:

DIET + EXERCISE + MEDICATION + GLUCOSE MONITORING + SMOKING CESSATION + HEALTHCARE ENGAGEMENT

Psychiatric illness can interfere with virtually every component.

Understanding the Diabetes

2. Diabetes Fundamentally Involves Insulin

Diabetes results from:

INSUFFICIENT INSULIN SECRETION

and/or

INSULIN RESISTANCE

3. Type 1 Diabetes Is Primarily an Autoimmune Disease

An autoimmune process selectively destroys pancreatic:

β CELLS

leading to minimal or absent endogenous insulin production.

4. Type 1 Diabetes Represents a Minority of Diabetes

The chapter gives approximately:

5–10%

of diabetes cases.

5. Type 2 Diabetes Is Primarily Characterised by Insulin Resistance

Over time, insulin production may also decline sufficiently that some patients ultimately require insulin.

6. Type 2 Diabetes Is Strongly Associated With Obesity and Genetic Vulnerability

Lifestyle interventions may be sufficient early in the illness, while later disease may require glucose-lowering medication and insulin.

Complications

7. Diabetes Is a Multisystem Disease

Complications can involve:

* heart

* brain

* peripheral circulation

* kidneys

* retina

* peripheral nerves

* gastrointestinal system

* skin and lower limbs

* immune function.

8. Diabetes Complications Create Their Own Psychological Burden

The emergence of:

NEUROPATHY • RETINOPATHY • RENAL DISEASE • VASCULAR DISEASE • AMPUTATION

can become critical periods for psychological distress.

Metabolic Syndrome

9. Metabolic Syndrome Is an Important Bridge Between Psychiatry and Diabetes

Its features include:

* central obesity

* elevated glucose

* hypertension

* low HDL

* elevated triglycerides.

10. Psychiatry Must Understand Metabolic Syndrome

Because both psychiatric illness and several psychiatric treatments can increase metabolic risk.

Depression and Diabetes

11. Depression Is Approximately Twice as Common in Diabetes

The chapter describes depressive disorders in approximately:

10–15%

of people with diabetes.

12. Subsyndromal Depression Is Even More Common

Potentially around:

25%

experience depressive symptoms below the threshold for a depressive disorder.

13. Major Depression May Be Chronic or Recurrent

The chapter describes high rates of prolonged symptoms and relapse.

This means depression in diabetes should not automatically be conceptualised as a temporary understandable reaction to illness.

14. Depression and Diabetes Have a Bidirectional Relationship

A useful model is:

DIABETES → DEPRESSION

but also:

DEPRESSION → POORER DIABETES OUTCOMES

15. The Psychological Explanation Is Only Part of the Story

Diabetes may increase depression through:

* chronic illness burden

* disability

* complications

* demanding treatment

* loss of control.

Depression may worsen diabetes through:

* reduced motivation

* reduced exercise

* poorer diet

* smoking

* reduced adherence

* missed appointments.

16. Shared Biological Mechanisms May Also Contribute

The chapter discusses possible roles for:

HYPERGLYCAEMIA

OXIDATIVE STRESS

MICROVASCULAR DISEASE

INFLAMMATION

HPA-AXIS FUNCTION

and other cellular signalling mechanisms.

The evidence does not establish one single mechanism.

Critical Transition Points

17. Psychiatric Symptoms May Emerge at Predictable Moments

Particularly:

DIAGNOSIS

↓

TREATMENT INTENSIFICATION

↓

STARTING INSULIN

↓

DEVELOPMENT OF COMPLICATIONS

↓

PROGRESSIVE DISABILITY

These are useful opportunities for proactive screening.

Screening

18. Do Not Wait for the Patient to Say “I Am Depressed”

Depression may instead present through:

* fatigue

* frustration

* resignation

* guilt

* hopelessness

* poor adherence

* apparent loss of diabetes control.

19. PHQ-9 Can Be Used for Depression Screening

The chapter specifically identifies it as a practical brief screening instrument.

20. GAD-7 Can Help Identify Anxiety

Particularly when anxiety is complicating diabetes management.

21. Diabetes-Specific Distress Is Not Necessarily Depression

The chapter also describes the Problem Areas in Diabetes (PAID) instrument for exploring diabetes-related emotional distress.

Diabetes Distress

22. Distress About Diabetes Can Be Understandable Without Constituting Major Depression

The patient may feel:

* overwhelmed

* frustrated

* frightened

* exhausted by self-management

* guilty about glucose readings

* worried about complications.

Assessment should distinguish this from a depressive disorder.

The Patient–Clinician Relationship

23. Diabetes Care Depends on Partnership

Effective management requires repeated collaboration between:

PATIENT ↔ FAMILY ↔ CLINICIANS

24. Trust Has Clinical Consequences

Satisfaction with healthcare is associated with better adherence.

25. Attachment Style May Affect Diabetes Management

The chapter particularly discusses:

DISMISSING ATTACHMENT

and

FEARFUL ATTACHMENT

as potentially interfering with trust and engagement with clinicians.

26. Dismissing Attachment May Produce Excessive Self-Reliance

The patient may be uncomfortable depending upon others even when assistance would improve disease management.

27. Fearful Attachment Can Create Approach–Avoidance

The person may want support during distress but simultaneously fear rejection or mistrust relationships.

28. Relationship Patterns Can Become Medical Variables

The chapter associates maladaptive attachment patterns with:

* missed appointments

* poorer glucose monitoring

* poorer medication adherence

* poorer lifestyle adherence

* reduced satisfaction with care.

This illustrates an important consultation-liaison principle:

RELATIONSHIPS CAN AFFECT PHYSIOLOGY THROUGH BEHAVIOUR

Type 1 Diabetes in Childhood

29. Childhood Diabetes Affects the Whole Family

Management can require parents to oversee:

* glucose monitoring

* insulin adjustment

* food

* exercise

* complications.

30. Parental Protection Can Become Developmentally Complicated

Understandable vigilance may interfere with the child’s development of:

MASTERY + AUTONOMY

Adolescence

31. Adolescence Creates a Collision Between Two Developmental Tasks

Diabetes demands:

CONTROL

Adolescence demands:

AUTONOMY

32. Apparent Non-Adherence May Have Developmental Meaning

Examples include:

* missing insulin

* dietary experimentation

* avoiding glucose checks.

These behaviours still carry serious medical consequences, but understanding their function can improve intervention.

33. Family Therapy May Be Useful

Especially where diabetes management has become a battleground between adolescents and parents.

Symptom Burden

34. Depression Can Amplify the Experience of Physical Symptoms

The chapter reports that depression and anxiety may correlate with reported diabetes symptoms more strongly than HbA1c or the number of complications.

35. Therefore Symptoms Have Both Disease and Perceptual Dimensions

OBJECTIVE PATHOLOGY ≠ SUBJECTIVE SUFFERING

Both matter clinically.

Pain

36. Diabetic Neuropathy and Depression Can Reinforce One Another

PAIN → DEPRESSION → GREATER PAIN EXPERIENCE → DISABILITY → DEPRESSION

37. Descending Pain Modulation May Be Relevant

Serotonergic and noradrenergic pathways contribute to pain regulation.

38. Some Antidepressants Can Therefore Treat Neuropathic Pain

The chapter particularly discusses:

DULOXETINE

and

VENLAFAXINE

among relevant options.

Function

39. Depression Adds Disability Beyond Diabetes Alone

The combination can substantially affect:

* work

* domestic functioning

* social functioning

* independence

* quality of life.

40. The Effects Can Be More Than Additive

Diabetes and depression can interact synergistically rather than merely contributing two separate burdens.

Depression, Obesity and Diabetes

41. Avoid Thinking of These as a Simple One-Way Chain

The relationship is better represented as:

DEPRESSION ↔ OBESITY ↔ TYPE 2 DIABETES

42. Potential Shared Pathways Include

* genetics

* serotonin

* HPA-axis function

* inflammation

* appetite

* insulin signalling

* leptin signalling

* physical activity.

43. Behavioural Factors Also Matter

Mental illness is associated with higher rates of:

SMOKING • POOR DIET • SEDENTARY BEHAVIOUR

which can increase metabolic risk.

Depression and Self-Management

44. Depression Attacks the Exact Functions Diabetes Requires

Diabetes asks for:

ENERGY

MEMORY

CONCENTRATION

MOTIVATION

PLANNING

CONSISTENCY

Depression can impair every one.

45. Depression and Anxiety Are Associated With Non-Adherence

The chapter cites a meta-analysis finding approximately:

3× HIGHER NON-ADHERENCE

to medical regimens among people with depression or anxiety in chronic medical illness.

Severe Mental Illness

46. Diabetes Management Can Be Particularly Difficult in Schizophrenia and Bipolar Disorder

Challenges can include:

* psychiatric symptoms

* cognitive difficulties

* reduced self-management

* lifestyle risk

* medication-related metabolic effects

* fragmented healthcare.

47. Physical Healthcare Inequality Matters

The chapter describes evidence that patients with schizophrenia and diabetes may receive less aggressive cardiovascular risk management.

The psychiatrist therefore has a role in advocating for ordinary high-quality physical healthcare.

Eating Disorders

48. Eating Disorders Are Particularly Important in Type 1 Diabetes

Bulimia nervosa appears more common than in control populations in the evidence reviewed.

49. Insulin Withholding Is a Particularly Dangerous Behaviour

Some insulin-dependent patients deliberately:

REDUCE OR OMIT INSULIN TO INFLUENCE WEIGHT

This creates serious risks from poor glycaemic control and future complications.

50. Ask About Eating Behaviour Directly

Including:

* binge eating

* purging

* emotional eating

* night eating

* insulin manipulation.

Anxiety and Hypoglycaemia

51. Anxiety and Hypoglycaemia Can Feel Similar

Both may involve:

SWEATING

TREMOR

PALPITATIONS

DIZZINESS

ANXIETY

52. Misinterpretation Can Occur in Both Directions

Anxiety interpreted as hypoglycaemia:

may cause catastrophising and unnecessary corrective behaviour.

Hypoglycaemia interpreted as anxiety:

may result in dangerous failure to respond.

Diabetes Complications and Depression

53. Depression Is Associated With Greater Risk of Diabetic Complications

The chapter reviews associations with both:

MICROVASCULAR

and

MACROVASCULAR

complications.

54. Again, the Relationship Is Bidirectional

DEPRESSION → COMPLICATIONS

while

COMPLICATIONS → DEPRESSION

55. Mechanisms Are Probably Multiple

Potential pathways include:

* poorer self-care

* smoking

* inactivity

* metabolic changes

* cortisol

* inflammation

* vascular processes.

Cardiovascular Risk

56. Cardiovascular Disease Is Central to Diabetes Mortality

The chapter notes that myocardial infarction and stroke account for a substantial proportion of deaths among people with diabetes.

57. Depression Further Increases Cardiovascular Risk

Potential mechanisms include changes in:

* autonomic activity

* heart-rate variability

* catecholamines

* inflammation

* endothelial function

* platelet function.

Cognition and Dementia

58. Type 2 Diabetes Is Associated With Cognitive Decline

Including increased risk of:

* cognitive impairment

* dementia

* Alzheimer’s disease

* vascular dementia.

59. Several Mechanisms May Contribute

Including:

INSULIN RESISTANCE

VASCULAR DISEASE

STROKE

HYPOGLYCAEMIA

60. Depression May Add Further Cognitive Risk

The chapter describes substantially increased dementia risk when depression and diabetes coexist.

61. Cognitive Decline Then Makes Diabetes Harder to Manage

Another feedback loop emerges:

DIABETES → COGNITIVE IMPAIRMENT → POORER SELF-MANAGEMENT → WORSE DIABETES

62. Cognitive Screening May Therefore Be Clinically Important

The chapter mentions tools including:

* MMSE

* MoCA.

63. Family Support Becomes Increasingly Important When Cognition Declines

Complex insulin and medication regimens may become unsafe without additional assistance.

Mortality

64. Depression in Diabetes Is Associated With Increased Mortality

The chapter reviews longitudinal evidence showing substantially increased mortality risk.

This makes depression identification part of serious medical care rather than merely quality-of-life care.

Treating Depression in Diabetes

65. Depression Is Treatable in People With Diabetes

Evidence supports benefit from:

* antidepressant medication

* psychotherapy

* collaborative care.

66. Improving Depression Does Not Automatically Normalise HbA1c

This is a critical distinction.

BETTER MOOD ≠ AUTOMATICALLY BETTER GLYCAEMIC CONTROL

67. Why?

Because metabolic control depends on multiple additional systems:

* medication optimisation

* diet

* exercise

* smoking

* glucose monitoring

* clinical follow-up

* treatment intensification.

68. Therefore Depression Treatment Alone May Be Insufficient

Integrated interventions addressing both psychiatric and medical disease are more logically suited to improving both outcomes.

Clinical Inertia

69. Do Not Blame Every Poor Outcome on Patient Non-Adherence

The chapter introduces another important problem:

CLINICAL INERTIA

70. Clinical Inertia Means Failure to Intensify Treatment When Required

For example, failing to adequately adjust treatment for:

* glucose

* blood pressure

* cholesterol.

71. Poor Diabetes Control Can Therefore Reflect Two Different Failures

PATIENT-LEVEL SELF-MANAGEMENT

and/or

HEALTH-SYSTEM TREATMENT INTENSIFICATION

This is an important antidote to automatically blaming the patient.

Collaborative Care

72. Collaborative Depression Care Improves Depression Outcomes

The chapter reviews several major primary-care trials supporting organised collaborative treatment.

73. But Depression-Focused Collaborative Care Alone May Not Improve HbA1c

Again, treating one component does not necessarily repair the whole system.

74. Multicondition Collaborative Care Goes Further

One particularly useful model simultaneously targets:

A - A1c

B - Blood pressure

C - Cholesterol

D - Depression

75. This Is a Powerful Mental Model

Instead of:

psychiatrist treats depression

and

physician treats diabetes

the team treats interconnected risks simultaneously.

76. Useful Behavioural Interventions Include

* motivational enhancement

* problem-solving therapy

* behavioural activation

* CBT

* exercise promotion

* adherence support.

Psychotropic Medication and Diabetes

77. Psychiatry Can Contribute to Metabolic Disease

Psychotropic medication choice must include metabolic consequences.

78. Clozapine and Olanzapine Carry Particularly High Weight-Gain Risk

The chapter’s table places both in the:

HIGH

weight-gain category.

79. Moderate Weight-Gain Risk Includes

* chlorpromazine

* quetiapine

* risperidone

* paliperidone.

80. Lower Weight-Gain Risk in the Chapter Includes

* aripiprazole

* amisulpride

* asenapine

* haloperidol

* ziprasidone

* lurasidone.

81. Weight Gain Is Not the Entire Mechanism

The chapter discusses evidence suggesting some atypical antipsychotics may also directly increase insulin resistance.

Metabolic Monitoring

82. Antipsychotic Treatment Requires Physical Health Monitoring

Assess:

PERSONAL HISTORY

FAMILY HISTORY

SMOKING

and monitor:

WEIGHT

WAIST CIRCUMFERENCE

BLOOD PRESSURE

FASTING GLUCOSE

LIPIDS

83. Other Psychotropics Can Also Increase Weight

The chapter highlights:

* valproate

* carbamazepine

* lithium

* tricyclic antidepressants

* mirtazapine.

84. Lamotrigine Is Generally Weight Neutral

Within the chapter’s discussion, it is not usually associated with significant weight gain.

85. Bupropion Is Also Metabolically Interesting

The chapter describes it as an antidepressant associated with little weight gain or slight weight loss in placebo-controlled trials.

86. Metformin May Help With Antipsychotic-Associated Weight Gain

This is discussed as one potential management strategy.

A Diabetes-Focused Psychiatric Assessment

87. Begin With the Patient’s Experience of Control

A useful opening question is:

“Has it recently felt as though your diabetes has become harder to control?”

This may reveal frustration, guilt, helplessness and depressive symptoms more naturally than immediately applying a diagnostic label.

88. Separate Stress From Depression

Clarify:

STRESS ≠ DEPRESSIVE DISORDER

although they can coexist.

89. Explore Symptom Overlap

Fatigue, altered appetite, sleep problems and cognitive difficulties may arise from:

* diabetes

* depression

* both.

90. Look for Behavioural Consequences

Ask about:

* prescriptions

* glucose monitoring

* insulin

* diet

* exercise

* smoking

* appointments

* healthcare avoidance.

91. Ask About Anxiety

Especially where the patient struggles to distinguish anxiety from hypoglycaemia.

92. Ask About Eating Behaviour

Including emotional eating, binge eating, purging and night eating.

93. Break Overwhelming Treatment Into Smaller Tasks

Depression can transform an already complex diabetes regimen into something psychologically unmanageable.

Instead of demanding improvement in everything:

PRIORITISE → SIMPLIFY → ACT → REVIEW

Diapression

94. The Chapter Introduces the Concept of “Diapression”

This describes the distinctive experience created when:

DIABETES + DEPRESSION

occur together.

95. Its Important Features Include

Depression can:

* mimic diabetes symptoms

* amplify diabetes symptoms

* impair self-management

* reduce adherence

* worsen lifestyle behaviours

* alter healthcare utilisation

* reduce trust and satisfaction with care.

96. The Central Clinical Principle

Diabetes demonstrates particularly clearly why psychiatry cannot divide illness neatly into mental and physical compartments.

The complete system is:

DIABETES

↓SYMPTOMS + TREATMENT BURDEN + COMPLICATIONS↓DISTRESS / DEPRESSION / ANXIETY↓MOTIVATION + COGNITION + BEHAVIOUR + RELATIONSHIPS↓SELF-MANAGEMENT↓GLYCAEMIC CONTROL↓

BACK TO DIABETES

And psychiatric medication itself can feed back into the metabolic system.

The task is therefore not simply to improve mood or lower glucose.

It is to restore the patient’s capacity to manage both simultaneously.

and psychiatric treatment.

Episode Description

Medlock Holmes enters The Chamber of Breath, an immense Neo-Victorian respiratory laboratory where a pair of mechanical lungs expands and contracts beneath an intricate network connecting the lungs, brain, emotions and behaviour.

At first, the mystery appears entirely pulmonary. Asthma narrows reactive airways. COPD progressively restricts airflow. Interstitial lung disease scars the tissue surrounding the alveoli. Cystic fibrosis fills the respiratory system with the consequences of abnormal CFTR function. Respiratory failure produces hypoxia and hypercapnia.

But Holmes quickly discovers that breathing is unlike almost any other bodily function.

It is simultaneously:

AUTOMATIC • VOLUNTARY • PHYSIOLOGICAL • PERCEPTUAL • EMOTIONAL

And this makes respiratory illness particularly important to psychiatry.

Dyspnoea can generate fear. Fear can alter breathing. Hyperventilation can create dizziness, chest tightness, paraesthesia and further breathlessness. Those sensations can then be interpreted catastrophically:

“I CAN’T BREATHE.”

The alarm intensifies.

Breathing accelerates.

Carbon dioxide falls.

Physical sensations increase.

Fear escalates again.

Holmes finds himself confronting one of respiratory psychiatry’s central diagnostic problems:

LUNG DISEASE → DYSPNOEA → FEAR

or

FEAR → HYPERVENTILATION → DYSPNOEA

or, very commonly:

BOTH

The source emphasises this reciprocal relationship: respiratory illnesses commonly involve dyspnoea, hypoxia and disturbed sleep, while severe disease can produce major functional impairment; together these can increase vulnerability to anxiety, depression and other psychiatric problems.

Asthma provides perhaps the clearest example. It is a genuine inflammatory airway disorder characterised by obstruction, inflammation, hyper-responsiveness and airway remodelling. Yet stress and emotion can themselves precipitate bronchoconstriction, while anxiety can alter the perception of airway obstruction. Some anxious patients may interpret benign respiratory sensations as evidence of an impending attack; others may underestimate dangerous obstruction and delay treatment.

The psychiatrist therefore must avoid two opposite mistakes:

“IT’S ALL ANXIETY.”

and

“IT’S ALL THE LUNGS.”

Both can be dangerous.

Holmes next enters the COPD chamber, where breathlessness has become persistent rather than episodic. Depression, anxiety and panic are common, while disability and frightening dyspnoea progressively narrow the patient’s world. Avoidance produces deconditioning; deconditioning makes activity harder; breathlessness increases; fear grows.

The vicious cycle becomes:

DYSPNOEA → FEAR → AVOIDANCE → DECONDITIONING → MORE DYSPNOEA

Pulmonary rehabilitation attempts to reverse this spiral by combining physical exercise with education, self-management, nutrition and psychosocial support.

Further along lies cystic fibrosis, where psychiatric care confronts a different burden: not simply breathlessness but the relentless demands of chronic disease management. Airway clearance, medications, nutrition, repeated appointments, infections, transitions from paediatric to adult services, fertility concerns and eventually decisions around transplantation can occupy enormous portions of a person’s life. Depression and anxiety may then impair the very adherence required to preserve physical health.

Holmes then reaches respiratory failure.

Here the psychiatric picture can change abruptly. Hypoxia and hypercapnia can disturb cerebral function, while critical illness, mechanical ventilation and intensive care create vulnerability to delirium, depression, anxiety and post-traumatic stress symptoms.

But perhaps the most deceptive corridor contains disorders in which respiratory symptoms are real even when conventional pulmonary pathology cannot adequately explain them.

Chronic hyperventilation produces hypocapnia. Vocal cord dysfunction can suddenly obstruct inspiration and mimic asthma. Tic cough and somatic cough disorder can produce persistent coughing. Sighing dyspnoea can create repeated sensations of unsatisfying breathing.

The historical word “psychogenic” becomes increasingly inadequate because Holmes discovers no clean border between mind and body. Respiratory sensations emerge from interactions between:

BRAIN ↔ AUTONOMIC SYSTEM ↔ RESPIRATORY MUSCLES ↔ AIRWAYS ↔ EMOTION ↔ ATTENTION

Finally, Holmes enters the pharmacy.

Here another clue emerges: sometimes psychiatric symptoms arise not from respiratory disease but from its treatment.

Corticosteroids can produce insomnia, irritability, depression, hypomania, mania, psychosis, cognitive impairment and occasionally delirium. Higher acute doses are particularly associated with manic or hypomanic presentations, whereas prolonged lower-dose exposure may be more associated with depression. Theophylline and β₂-agonists may contribute to anxiety and agitation.

The final lesson becomes clear.

The psychiatrist’s question is not simply:

“Does this patient have lung disease or anxiety?”

It is:

“HOW ARE THE LUNGS, BRAIN, BREATHING BEHAVIOUR, EMOTIONS AND TREATMENTS INTERACTING IN THIS PERSON?”

Key Takeaways

1. Respiratory Disease and Psychiatry Are Bidirectionally Connected

Respiratory illness can influence mental health.

Mental health can influence respiratory symptoms, illness behaviour and disease management.

2. Four Features Are Particularly Important

Respiratory disorders frequently involve:

DYSPNOEA

HYPOXIA

POOR SLEEP

INSOMNIA

All may contribute to psychiatric symptoms.

3. Functional Impairment Also Matters

Severe respiratory disease can restrict:

* exercise

* employment

* social activity

* independence

* sleep

* everyday functioning.

This increases vulnerability to depression and anxiety.

4. Psychiatric Comorbidity Can Worsen Respiratory Outcomes

It can influence:

* adherence

* symptom interpretation

* smoking

* physical activity

* treatment seeking

* rehabilitation

* emergency healthcare use.

The Psychiatrist’s Role

5. Diagnose and Treat Psychiatric Comorbidity

Particularly:

* anxiety

* panic

* depression

* sleep disturbance

* cognitive impairment

* trauma-related symptoms.

6. Identify Psychosocial Triggers

Stress and emotional states can influence respiratory symptoms in some patients.

7. Address the Psychological Consequences of Chronic Illness

This includes:

* loss

* disability

* fear

* reduced independence

* treatment burden

* end-of-life concerns.

8. Support Disease Self-Management

Psychiatric care may improve:

ADHERENCE • MOTIVATION • REHABILITATION • LIFESTYLE CHANGE • FAMILY MANAGEMENT

Asthma

9. Asthma Is a Chronic Inflammatory Airway Disease

Its major pathological features include:

OBSTRUCTION

INFLAMMATION

HYPER-RESPONSIVENESS

AIRWAY REMODELLING

10. Asthmatic Airways Are Hyper-Reactive

Triggers can include:

* allergens

* exercise

* pollutants

* irritants and odours

* cold air

* respiratory infections

* some medications

* reflux

* psychological stress

* emotion.

11. Common Asthma Symptoms Include

DYSPNOEA

CHEST TIGHTNESS

COUGH

WHEEZE

12. Asthma Episodes Can Also Produce Psychological Symptoms

Including:

* fear

* anxiety

* panic

* irritability

* fatigue.

13. Asthma Does Not Have One Definitive Diagnostic Test

Assessment can combine:

* clinical history

* examination

* spirometry

* reversibility testing

* airway inflammation

* bronchial challenge testing

* allergy assessment.

Asthma Treatment

14. Inhaled Corticosteroids Are Central Maintenance Treatment

They target the underlying airway inflammation.

15. Bronchodilators Relieve Bronchoconstriction

Short-acting β-adrenergic agents are described as rescue medications in the source.

16. Severe Exacerbations May Require Systemic Corticosteroids

This becomes psychiatrically important because systemic corticosteroids themselves can produce major psychiatric adverse effects.

Adherence

17. Asthma Requires Considerable Self-Management

Patients may need to:

* take regular medication

* monitor symptoms

* adjust treatment according to action plans

* identify triggers

* modify their environment.

18. Poor Adherence Is Common

The source estimates that roughly:

HALF OF PATIENTS

show suboptimal medication adherence.

19. “No Symptoms, No Asthma” Is a Dangerous Illness Belief

The patient may conclude:

I FEEL WELL → I DON’T HAVE ASTHMA → I DON’T NEED PREVENTER MEDICATION

This can leave underlying disease inadequately controlled.

20. Rescue Medication Can Reinforce This Misunderstanding

The person treats symptoms only when they appear rather than controlling the underlying inflammatory disease.

21. Adherence Is Not Simply a Matter of Motivation

Barriers can include:

* illness beliefs

* medication costs

* health literacy

* social disadvantage

* family factors

* environmental exposures.

Stress and Asthma

22. Emotion Can Be a Genuine Asthma Trigger

Emotional triggers are reported by approximately:

ONE-QUARTER

of patients as among their major triggers.

23. Laboratory Studies Support Physiological Effects

The source reports clinically relevant airway obstruction during stress or emotion induction in approximately:

20–40%

of patients studied.

24. This Does Not Mean Asthma Is “Psychological”

Asthma remains an inflammatory airway disorder.

Psychological states can nevertheless interact with its physiology.

25. Stress May Influence the Airways Through Several Mechanisms

Including:

* parasympathetic activation

* altered breathing

* hypocapnia

* CNS pathways

* inflammatory mechanisms.

26. Chronic Adversity May Also Matter

The source discusses associations involving:

* socioeconomic disadvantage

* negative life events

* psychosocial stress

* immune changes

* airway inflammation

* microbiome alterations

* epigenetic processes.

Perception of Breathlessness

27. Respiratory Symptoms Must Be Perceived Before They Can Be Reported

This creates an important psychological dimension to asthma management.

28. Some Patients Overestimate Airway Obstruction

High anxiety may amplify interpretation of respiratory sensations.

This can contribute to:

* excessive rescue inhaler use

* unnecessary healthcare presentations

* fear of attacks.

29. Others Underestimate Obstruction

This can be even more dangerous.

Failure to recognise severe obstruction may lead to:

DELAYED TREATMENT → LIFE-THREATENING EXACERBATION

30. The Brain Participates in Dyspnoea Perception

The source particularly identifies limbic structures including the:

RIGHT ANTERIOR INSULA

as relevant to the perception of breathlessness.

Asthma and Anxiety

31. Anxiety Disorders Are More Common in Asthma

Associations include:

* panic disorder

* agoraphobia

* GAD

* PTSD

* social phobia.

32. Asthma and Panic Can Be Difficult to Distinguish

Both can produce:

SHORTNESS OF BREATH

CHEST TIGHTNESS

FEAR

AUTONOMIC AROUSAL

33. Hyperventilation Can Create a Feedback Loop

FEAR

↓OVERBREATHING↓HYPOCAPNIA↓DIZZINESS + CHEST SENSATIONS + DYSPNOEA↓CATASTROPHIC INTERPRETATION↓

MORE FEAR

34. Bronchodilators Will Not Fully Correct Anxiety-Driven Hyperventilation

This can provide an important clinical clue.

35. Asthma and Panic Can Coexist

Therefore:

PANIC SYMPTOMS ≠ NO ASTHMA

and

ASTHMA ≠ NO PANIC

36. Suffocation-Alarm Theory Provides One Possible Link

Repeated respiratory experiences may sensitise systems involved in detecting perceived suffocation and CO₂ changes.

Asthma and Depression

37. Depression Is Also More Common in Asthma

The relationship may operate in both directions.

38. Depression Can Interfere With Asthma Management

Through:

* reduced motivation

* poorer adherence

* smoking

* reduced activity

* poorer trigger control

* delayed treatment seeking.

Sleep

39. Sleep Disorders Are Increased in Asthma

The source reports insomnia and obstructive sleep apnoea occurring around:

2.5 TIMES MORE OFTEN

than among people without asthma.

40. Nocturnal Asthma Can Mimic or Conceal Sleep Disorders

Night-time wheezing may distract clinicians from coexisting sleep apnoea or insomnia.

41. Poor Sleep Can Then Worsen Mental Health

Creating another reciprocal loop:

ASTHMA ↔ POOR SLEEP ↔ MOOD/ANXIETY

Cognition

42. Asthma Has Also Been Associated With Cognitive Problems

Studies discussed in the source report associations with:

* mild cognitive impairment

* subsequent dementia

* cognitive decline.

The causal mechanisms remain uncertain.

43. Possible Mechanisms Include

* impaired respiratory function

* inflammation

* medication effects

* chronic disease burden.

Treating Psychiatric Disorders in Asthma

44. Medication Requires Respiratory Awareness

Psychotropic treatment cannot be prescribed without considering pulmonary consequences.

45. High-Dose Benzodiazepines and Hypnotics Require Caution

They can cause:

RESPIRATORY DEPRESSION

and are particularly concerning in vulnerable respiratory patients.

46. CBT Can Be Adapted for Asthma

Potential components include:

* cognitive restructuring

* psychoeducation

* relaxation techniques

* interoceptive work

* breathing retraining

* asthma education.

47. Standard Panic Techniques May Need Modification

Deliberately inducing hyperventilation as an exposure exercise may be inappropriate in some patients with respiratory disease.

Breathing Retraining

48. Dysfunctional Breathing Can Be Modified

Training may focus on breathing that is:

SLOWER • SHALLOWER • ABDOMINAL • REGULAR • NASAL

49. Simply Taking Deep Breaths Is Not Always Helpful

Repeated exaggerated deep breathing can reduce CO₂ and potentially worsen hypocapnia.

50. “Take a Deep Breath” Is Therefore Not Universal Respiratory Advice

The pattern and physiology of breathing matter.

51. Capnometry Can Provide Feedback

CO₂ monitoring can help patients learn breathing patterns that reduce hypocapnia.

COPD

52. COPD Is Progressive and Irreversible

It includes conditions such as:

* emphysema

* chronic bronchitis.

The central physiological problem is progressive airflow limitation.

53. Dyspnoea Is Often Continuous

Unlike episodic asthma, COPD can produce persistent, frightening breathlessness.

54. Tobacco Smoking Is the Major Risk Factor

The source associates smoking with approximately:

80%

of COPD cases in the populations discussed.

55. Other Risks Include

* biomass fuel exposure

* fumes

* environmental irritants

* genetic susceptibility.

56. Depression Is Common in COPD

The source reports approximately:

25–50%

57. Risk Factors for Depression Include

* greater disease severity

* dyspnoea

* disability

* female sex.

58. Functional Impairment May Be Particularly Important

Depression may relate more strongly to functional limitation than to objective severity of lung disease.

59. Anxiety and Panic Are Also Increased

Breathlessness itself provides an understandable stimulus for fear.

60. COPD Can Generate a Self-Reinforcing Cycle

BREATHLESSNESS

↓FEAR↓ACTIVITY AVOIDANCE↓DECONDITIONING↓GREATER BREATHLESSNESS

COPD Rehabilitation

61. Pulmonary Rehabilitation Is Multidisciplinary

It can include:

* exercise

* education

* self-management

* nutrition

* psychosocial support.

62. Rehabilitation Can Improve

* exercise tolerance

* dyspnoea

* quality of life

* exacerbation rates.

63. Psychological Components Can Add Benefit

Stress management and psychotherapy may improve depression.

64. CBT Can Reduce Anxiety

The source also describes reductions in healthcare utilisation.

65. Acceptance and Existential Issues May Become Important

Particularly in advanced COPD, therapy may need to address:

* progressive disability

* mortality

* loss

* meaning

* approaching end of life.

COPD and Cognition

66. Cognitive Impairment Is Common

Particularly involving:

* attention

* working memory.

67. Cognitive Problems May Worsen With Disease Progression

Coexisting obstructive sleep apnoea can further contribute.

Smoking and Psychiatry

68. Smoking Complicates Interpretation of COPD–Psychiatry Associations

Nicotine dependence itself is associated with psychiatric illness.

69. Smoking Is Particularly Common in Some Severe Mental Illnesses

Especially schizophrenia.

This increases subsequent COPD risk.

70. Smoking Cessation Is Therefore Psychiatric Treatment Too

It is not merely a respiratory intervention.

Interstitial Lung Disease

71. ILD Is a Diverse Group of Disorders

Examples include:

* sarcoidosis

* asbestosis

* hypersensitivity pneumonitis

* drug-related disease

* some infection-related conditions.

72. Progressive Fibrosis Produces Increasing Dyspnoea

The psychological burden rises alongside physical restriction.

73. Depression and Anxiety Are Commonly Reported

Particularly in idiopathic pulmonary fibrosis, and are related to dyspnoea severity.

Cystic Fibrosis

74. CF Is Autosomal Recessive

It results from abnormalities of:

CFTR

on chromosome 7.

75. CFTR Regulates Chloride Transport

Affected tissues include:

* lungs

* sweat glands

* sinuses

* pancreas

* gastrointestinal tract

* reproductive organs.

76. CF Is a Multisystem Disease

Possible manifestations include:

* recurrent respiratory infections

* cough

* wheeze

* breathlessness

* pancreatic insufficiency

* nutritional problems

* digestive problems

* reproductive difficulties.

77. Progressive Respiratory Disease Is Central

Repeated infection and bacterial colonisation gradually reduce lung function.

78. Treatment Is Extremely Demanding

Daily management may involve:

AIRWAY CLEARANCE + AEROSOLISED MEDICATION + NUTRITION + SUPPLEMENTS + ANTIBIOTICS + ANTI-INFLAMMATORY TREATMENT

79. Treatment Burden Itself Can Affect Mental Health

A person may spend substantial portions of everyday life managing the illness.

CF and Development

80. Improved Survival Creates New Psychological Challenges

More people with CF now navigate:

* adulthood

* relationships

* careers

* fertility

* parenthood

* transition to adult healthcare.

81. Transition From Paediatric to Adult Services Can Be Difficult

Patients may be leaving teams that have cared for them for many years.

Continuity and communication matter.

82. Fertility Is Clinically Important

Most males with CF lack a vas deferens, producing infertility.

Female fertility can also be affected.

CF and Mental Health

83. Depression Is Common

The source reports depressive symptoms in approximately:

5–19% of adolescents

and

13–29% of adults

with CF.

84. Anxiety Is Also Common

Approximately:

14–35%

across studies described.

85. Anxiety and Depression Frequently Coexist

Patients reporting anxiety were substantially more likely also to report depressive symptoms.

86. Caregiver Mental Health Matters

High levels of anxiety and depression are also reported among parents and caregivers.

87. Family Functioning Can Affect Patient Outcomes

Especially during childhood and adolescence.

88. Depression and Anxiety Can Affect CF Treatment

They are associated with:

* poorer adherence

* poorer lung function

* greater healthcare costs

* poorer quality of life.

89. Psychological Monitoring Should Be Routine

Mental health should not be treated as an optional addition to CF care.

Respiratory Failure

90. Respiratory Failure Can Produce Major Neuropsychiatric Consequences

Particularly through:

HYPOXIA

and

HYPERCAPNIA

91. Delirium Is Common

Acute cognitive disturbance in severe respiratory illness should trigger consideration of physiological causes.

92. Mechanical Ventilation and ICU Treatment Can Be Traumatic

Subsequent presentations may include:

* depression

* anxiety

* PTSD symptoms.

Functional and Somatoform Respiratory Disorders

93. Not Every Distressing Respiratory Symptom Reflects Structural Lung Disease

Functional abnormalities of respiratory regulation can produce very real symptoms.

94. “Psychogenic” Is Increasingly an Inadequate Label

Modern neuroscience demonstrates close interaction between:

MENTAL

NEUROPHYSIOLOGICAL

AUTONOMIC

and

SOMATIC

processes.

Chronic Hyperventilation

95. Hyperventilation Means Ventilation Exceeds Metabolic Demand

The consequence is:

↓ arterial PCO₂

96. Symptoms Can Include

* dizziness

* headache

* chest pain

* paraesthesia

* anxiety

* breathlessness

* air hunger.

97. The Paradox Is Important

The patient is breathing too much but feels:

“I CAN’T GET ENOUGH AIR.”

98. Acute Hyperventilation Produces Respiratory Alkalosis

CO₂ falls and pH rises.

99. Chronic Hyperventilation May Have Near-Normal pH

Renal bicarbonate compensation can partly restore acid–base balance.

100. Panic Is a Common Trigger

But chronic hyperventilation can also occur without an anxiety disorder.

101. Treatment Focuses on Reducing Hypocapnia

Strategies include:

* slower breathing

* shallower breathing

* abdominal breathing

* nasal breathing

* trigger identification

* decatastrophising

* psychoeducation.

102. Paper-Bag Rebreathing Is Discouraged

It can reduce oxygenation and increasing CO₂ may itself provoke panic.

Vocal Cord Dysfunction

103. Vocal Cord Dysfunction Can Mimic Asthma

The cords paradoxically narrow or close, commonly during:

INSPIRATION

104. Typical Features Include

* sudden dyspnoea

* inspiratory difficulty

* throat localisation

* intermittent episodes

* spontaneous resolution within minutes.

105. Laryngoscopy Can Confirm the Diagnosis

Flow-volume loops may also demonstrate abnormalities.

106. Fear of Suffocation Is Common

An episode can therefore generate substantial panic and anticipatory anxiety.

107. Triggers Are Diverse

Including:

* stress

* anxiety

* exercise

* irritants

* reflux

* infection

* postnasal drip

* odours.

108. Failure to Respond to Bronchodilators Is an Important Clue

Particularly when asthma investigations do not demonstrate airway hyper-reactivity.

109. Treatment Is Often Multidisciplinary

Potential approaches include:

SPEECH THERAPY + BEHAVIOURAL THERAPY + TREATMENT OF PHYSICAL TRIGGERS

Chronic Cough

110. Chronic Cough Has Many Physical Causes

Before considering functional explanations, assess possibilities such as:

* infection

* asthma

* COPD

* reflux

* allergic rhinitis

* postnasal drip.

111. “Habit Cough” Has Been Reframed as Tic Cough

This reflects similarities with tics:

* suppressibility

* distractibility

* suggestibility

* variability

* premonitory urge.

112. “Psychogenic Cough” Has Also Been Reconsidered

The source discusses the term:

SOMATIC COUGH DISORDER

113. Functional Diagnosis Should Not Simply Mean “Tests Were Normal”

Appropriate positive features and exclusion of relevant alternatives remain important.

Sighing Dyspnoea

114. Sighing Dyspnoea Involves Recurrent Deep Sighs

It may be associated with:

* breathlessness

* chest discomfort

* yawning

* anxiety.

115. Panic Can Be Associated With Increased Sighing

Frequent deep breaths may help maintain hypocapnia.

116. Breathing Retraining Focuses on Regularity

The aim is not necessarily to eliminate normal occasional sighs.

Respiratory Medicines and Psychiatry

117. Always Ask What Medication the Patient Is Taking

Psychiatric symptoms may be:

DISEASE-RELATED

or

TREATMENT-RELATED

or both.

Corticosteroids

118. Systemic Corticosteroids Can Produce Major Psychiatric Effects

Including:

* insomnia

* irritability

* depression

* hypomania

* mania

* mixed mood states

* psychosis

* cognitive impairment

* delirium.

119. Acute High-Dose Treatment Is Particularly Associated With Mania or Hypomania

This is especially relevant during corticosteroid bursts for respiratory exacerbations.

120. Chronic Lower-Dose Exposure May Be More Associated With Depression

The temporal relationship between medication exposure and symptoms is therefore crucial.

121. Psychotic Symptoms Can Occur

Including:

DELUSIONS

and

HALLUCINATIONS

122. Corticosteroids Can Affect Memory

The hippocampus appears particularly sensitive to glucocorticoid effects.

123. Even Brief Exposure Can Affect Cognition

The source discusses changes in:

* declarative memory

* working memory.

124. Older Adults May Develop More Generalised Cognitive Disturbance

Including delirium.

125. Dose Is the Clearest Established Risk Factor

Therefore:

USE THE LOWEST EFFECTIVE CORTICOSTEROID DOSE

when clinically possible.

126. If Steroid Reduction Is Impossible, Treat the Psychiatric Syndrome

The source discusses clinical use of:

* lithium

* anticonvulsants

* antipsychotics

for corticosteroid-associated mood or psychotic symptoms, while noting limitations in controlled evidence.

Other Respiratory Medicines

127. Theophylline Can Produce Psychiatric Symptoms

Reported effects include:

* anxiety

* agitation

* depression.

128. β₂-Adrenergic Agonists Can Also Produce Anxiety and Agitation

Their physiological effects can sometimes resemble anxiety symptoms.

129. Leukotriene Inhibitors Have Generated Neuropsychiatric Concern

Post-marketing reports discussed in the source include:

* agitation

* insomnia

* anxiety

* depression

* suicidal ideation.

The chapter also emphasises uncertainty in the evidence and does not support a simplistic causal conclusion.

The Diagnostic Challenge

130. Breathlessness Has Multiple Possible Origins

When a patient says:

“I CAN’T BREATHE”

consider:

AIRWAY OBSTRUCTION

PARENCHYMAL LUNG DISEASE

HYPOXIA

HYPERCAPNIA

HYPERVENTILATION

PANIC

VOCAL CORD DYSFUNCTION

CARDIORESPIRATORY DISEASE

MEDICATION EFFECTS

and combinations of these.

131. Do Not Prematurely Psychologise Respiratory Symptoms

An anxious patient can still have life-threatening asthma.

132. Do Not Ignore Psychological Amplification Either

Objective lung disease does not prevent panic, hyperventilation or catastrophic interpretation from simultaneously worsening symptoms.

133. The Most Useful Model Is Bidirectional

LUNGS ↔ BRAIN

BREATHING ↔ EMOTION

SYMPTOMS ↔ INTERPRETATION

MENTAL HEALTH ↔ SELF-MANAGEMENT

MEDICATION ↔ BOTH

134. The Central Principle

Holmes begins with a simple question:

“Is the breathlessness physical or psychological?”

But the investigation reveals that this is often the wrong question.

A better model is:

RESPIRATORY DISEASE

↓DYSPNOEA / HYPOXIA / SLEEP DISTURBANCE↓FEAR • ANXIETY • DEPRESSION • COGNITIVE CHANGE↓BREATHING BEHAVIOUR • ADHERENCE • ACTIVITY • TREATMENT SEEKING↓RESPIRATORY CONTROL↓

BACK TO THE LUNGS

The clinical task is therefore not to choose between mind and body.

It is to understand the system connecting them.

the development and management of obesity.

Medlock Holmes enters The Great Energy Exchange, an immense Neo-Victorian metabolic laboratory where every calorie entering the body passes through a bewildering network of biological, psychological and environmental machinery.

At first, the equation appears almost embarrassingly simple:

ENERGY IN > ENERGY OUT → WEIGHT GAIN

But Holmes quickly discovers that the equation describes what happens, not why it happens.

Behind the balance are hundreds of interconnected mechanisms: genetic susceptibility, appetite hormones, adipose tissue, metabolism, the gut microbiome, reward circuitry, mood, stress, sleep, learned behaviour, medications, food availability and the environment itself. Obesity is therefore not simply a failure of willpower; it is a complex condition emerging from the interaction between biology and the world in which a person lives.

The investigation begins with measurement. Body mass index, calculated as weight in kilograms divided by height in metres squared, remains the most widely used clinical measure. A BMI of 25–29.9 falls within the overweight range, 30 or above within obesity, and above 40 within severe obesity. Yet Holmes notices immediately that BMI is an imperfect instrument: it cannot distinguish muscle from fat or account adequately for fitness, bone density and other dimensions of metabolic health.

More important is what obesity does across the body. The medical map on the wall connects it with hypertension, dyslipidaemia, type 2 diabetes, cardiovascular disease, obstructive sleep apnoea, osteoarthritis, fatty liver disease, reflux, reproductive difficulties and several cancers. Depression and anxiety appear on the same map.

But Holmes refuses to draw a one-way arrow from obesity to mental illness.

Instead:

OBESITY ↔ DEPRESSION

OBESITY ↔ ANXIETY

OBESITY ↔ DISORDERED EATING

and, in severe mental illness:

PSYCHIATRIC ILLNESS ↔ MEDICATION ↔ WEIGHT ↔ PHYSICAL HEALTH

One particularly important chamber contains the psychiatric dispensary. Olanzapine, clozapine, quetiapine, lithium, valproate, mirtazapine and several other psychotropics can contribute to weight gain. The psychiatrist therefore cannot simply prescribe for the mind while ignoring the metabolic consequences for the body.

Another chamber contains food, but Holmes discovers that eating is not always driven by hunger.

For some people:

DISTRESS → EATING → TEMPORARY RELIEF

Repeated often enough, food can become an emotion-regulation strategy. Binge eating, grazing and night eating may further complicate obesity, while highly palatable foods engage reward pathways that have prompted comparisons with addictive processes.

Outside the laboratory lies an even larger clue: the obesogenic environment. Calorie-dense food is inexpensive and readily available, while transport, screens, sedentary employment and energy-saving technologies progressively remove physical activity from everyday life.

Treatment must therefore be equally multidimensional.

Holmes walks through rooms devoted to nutrition, exercise, behavioural weight management, CBT, mindfulness and acceptance-based approaches, motivational interviewing, medication and bariatric surgery. None represents a universal solution.

Behavioural treatment teaches self-monitoring, goal setting, stimulus control and sustainable habit change. CBT adds an investigation of the thoughts that can transform one setback into abandonment:

“I ate one biscuit” → “I’ve ruined everything” → “I might as well give up.”

Acceptance-based approaches teach people to experience cravings and uncomfortable emotions without automatically responding through eating.

Motivational interviewing asks an even earlier question:

Is the person ready to change?

Because prescribing action to somebody still contemplating change may simply produce disengagement.

And then Holmes encounters perhaps the hardest mystery of all: maintenance. Losing weight and maintaining that loss are not the same task. Relapse and weight regain are common, meaning obesity frequently requires long-term management rather than a single successful intervention.

At the far end of the laboratory stands bariatric surgery - the most powerful long-term intervention described in the source for severe obesity. Yet even surgery does not remove psychology from the equation. Candidates require careful assessment of expectations, eating behaviour, psychiatric stability, substance use, coping and social support, while psychological monitoring remains important afterwards.

Holmes finally replaces the simplistic inscription:

EAT LESS. MOVE MORE.

with a much larger equation:

BIOLOGY × ENVIRONMENT × REWARD × EMOTION × BEHAVIOUR × TREATMENT × TIME

Obesity is not merely about how much energy enters the body.

The real mystery is what determines that behaviour, how the body responds to it, and how sustainable change can be supported without stigma or blame.

Key Takeaways

1. Obesity Is a Major Health Condition

Obesity has substantial:

* physical

* psychological

* social

* economic

consequences.

2. BMI Remains the Most Common Measure

BMI = weight (kg) ÷ height² (m²)

3. Adult BMI Categories

Underweight: <18.5Normal: 18.5–24.9Overweight: 25–29.9Obesity class I: 30–34.9Obesity class II: 35–39.9Severe/class III obesity: ≥40

4. BMI Is an Imperfect Measure

It does not adequately distinguish:

* muscle from fat

* bone density

* fitness

* fat distribution

* broader metabolic health.

5. Waist Circumference Provides Additional Information

Central adiposity can provide useful information about metabolic risk beyond BMI alone.

6. Childhood Obesity Requires Age- and Sex-Specific Assessment

Children are assessed using BMI percentiles rather than adult cut-offs.

Why Obesity Matters

7. Obesity Affects Almost Every Organ System

Associated conditions include:

* hypertension

* dyslipidaemia

* type 2 diabetes

* coronary disease

* stroke

* fatty liver disease

* gallstones

* reflux

* osteoarthritis

* obstructive sleep apnoea

* respiratory disease

* infertility

* PCOS

* urinary incontinence

* thromboembolism

* gout

* some cancers.

8. Mental Health Is Part of the Medical Burden

The source’s whole-body diagram on page 4 explicitly includes depression alongside cardiovascular, respiratory, metabolic, gastrointestinal and musculoskeletal complications.

Obesity should therefore never be conceptualised as purely cosmetic.

9. Childhood Obesity Predicts Later Risk

Children with obesity are more likely to develop adult obesity and associated cardiometabolic complications.

10. Appropriate Medical Assessment Matters

Depending upon presentation, assessment may include:

* lipids

* blood pressure

* glucose

* thyroid function

* vitamin status

* assessment for obstructive sleep apnoea.

Why Does Obesity Develop?

11. The Basic Energy Equation Is Correct but Incomplete

At the most fundamental level:

ENERGY IN > ENERGY EXPENDITURE → ENERGY STORAGE

But this tells us little about why the imbalance develops.

12. Obesity Is Multifactorial

Think:

GENES + BIOLOGY + ENVIRONMENT + BEHAVIOUR + PSYCHOLOGY

13. Genetics Have a Major Role

The source describes hundreds of genetic mutations and genomic regions potentially related to obesity.

14. Weight Shows Substantial Heritability

Twin and adoption research cited in the chapter estimates that genetic differences may account for approximately:

55–85%

of variance in weight.

This does not mean weight is predetermined.

15. The “Thrifty Genotype” Provides an Evolutionary Model

Genes favouring efficient energy storage may once have provided survival advantages during periods of food scarcity.

Those same biological tendencies exist in a radically different modern environment.

16. Adipose Tissue Is Biologically Active

Fat tissue is not simply passive energy storage.

Enlarged adipocytes may influence:

* inflammation

* leptin

* insulin

* adiponectin

* metabolic homeostasis.

17. The Gut Microbiome May Also Contribute

Gut microorganisms may influence:

* dietary energy utilisation

* energy expenditure

* energy storage.

The Obesogenic Environment

18. Genetics Alone Cannot Explain the Rapid Rise in Obesity

Human genetics have not changed rapidly enough to account for the population-level increase.

The environment has.

19. Modern Environments Promote Positive Energy Balance

Many environments provide:

HIGH FOOD AVAILABILITY + ENERGY-DENSE FOOD + LOW REQUIRED ACTIVITY

20. Everyday Life Has Become Less Physically Demanding

Examples include:

* cars

* television

* sedentary employment

* supermarkets

* labour-saving technologies.

21. Modern Humans Must Often Deliberately Choose Activity

Physical activity that once occurred automatically during everyday survival increasingly has to be intentionally scheduled.

22. Biology and Environment Interact

A biological tendency to:

SEEK ENERGY + CONSERVE ENERGY

becomes particularly important in an environment offering:

ABUNDANT CALORIES + MINIMAL REQUIRED EXERTION

Reward and “Food Addiction”

23. People Differ in Their Responsiveness to Food Cues

Food-cue susceptibility may influence:

* cravings

* dietary adherence

* BMI.

24. Highly Palatable Food Engages Reward Systems

Repeated exposure may influence dopaminergic reward processes.

25. “Food Addiction” Has Been Proposed as a Model

The concept attempts to explain compulsive patterns of consumption involving highly palatable foods.

It remains a conceptual framework rather than simply making obesity itself an addictive disorder.

26. The Yale Food Addiction Scale Has Been Used to Study This

The source reports a pooled prevalence of approximately:

19.9%

across adult samples studied.

27. Rates Were Higher Among People With Overweight or Obesity

The figures reported were approximately:

24.9% vs 11.1%

compared with healthy-weight controls.

28. Rates Were Particularly High in Disordered-Eating Samples

The source reports:

57.6%

versus:

16.2%

among samples without eating-disorder diagnoses.

Emotional Eating

29. Humans Do Not Eat Only Because They Are Hungry

Common emotional triggers include:

* stress

* boredom

* fatigue

* anxiety

* sadness

* depression.

30. Food Can Become an Emotion-Regulation Strategy

A crucial cycle is:

DISTRESS → EATING → TEMPORARY RELIEF → LEARNING

Repeated often enough, the behaviour becomes increasingly automatic.

31. Emotional Eating May Begin Early

The pattern may develop during childhood and continue into adulthood.

32. Experiential Avoidance Can Maintain Emotional Eating

The person may not simply be seeking food.

They may be trying to escape:

ANXIETY • SADNESS • BOREDOM • STRESS • CRAVING

Personality and Behaviour

33. Some Personality Dimensions Are Associated With Obesity

The source particularly discusses:

* neuroticism

* impulsivity

* reward sensitivity.

34. Higher Reward Sensitivity May Increase Vulnerability

Highly rewarding food cues can become more difficult to resist.

35. Conscientiousness and Self-Control May Be Protective

These traits may facilitate regulation of urges and maintenance of behavioural goals.

They should not, however, be converted into moral judgements about body weight.

Eating Disorders and Obesity

36. Obesity and Eating Disorders Are Different Concepts

Obesity is not itself an eating disorder.

But eating disorders may coexist with obesity.

37. Binge-Eating Disorder Is Particularly Important

BED involves:

LARGE AMOUNT OF FOOD + LOSS OF CONTROL

38. BED Requires Recurrent Episodes

The source specifies at least:

ONCE PER WEEK FOR 3 MONTHS

39. Associated BED Features Include

At least three such features as:

* eating rapidly

* eating until uncomfortably full

* eating without hunger

* eating alone because of embarrassment

* guilt or disgust afterwards.

Marked distress is required.

40. BED Does Not Involve Regular Compensatory Behaviour

This distinguishes it from bulimia nervosa.

41. BED Is Common Among People With Obesity

The chapter estimates a prevalence around:

30%

among patients with obesity in the populations discussed.

Grazing

42. Grazing Is Different From Binge Eating

It involves repeated or continuous consumption over a prolonged period rather than a discrete large binge.

43. Loss of Control Is Not Always Present During Grazing

This distinguishes some grazing behaviour from BED.

44. High-Calorie Liquid Grazing Can Also Occur

Calories can be consumed continuously through beverages without conventional meals or binges.

Night Eating Syndrome

45. Night Eating Syndrome Involves Circadian Displacement of Eating

The core pattern involves:

EVENING HYPERPHAGIA

and/or

NOCTURNAL EATING

46. Associated Features Include

* insomnia

* morning anorexia

* night-time urges to eat

* depressed evening mood

* belief that eating is necessary to sleep.

47. Symptoms Must Cause Distress

The proposed criteria in the source require persistence for:

≥3 MONTHS

Obesity and Depression

48. Depression and Obesity Frequently Coexist

The source reports estimates of depression among people with obesity ranging from approximately:

19–66%

depending upon the population studied.

49. The Relationship Is Reciprocal

Think:

OBESITY ↔ DEPRESSION

50. Obesity May Contribute to Depression Through

* impaired physical health

* functional limitation

* body-image difficulties

* reduced activity

* reduced quality of life

* stigma.

51. Depression May Contribute to Obesity Through

* appetite changes

* low energy

* reduced activity

* stress responses

* maladaptive eating

* treatment difficulties

* medication effects.

52. Stigma Is Clinically Important

Weight stigma may itself worsen:

* depression

* anxiety

* self-esteem

* social withdrawal

* treatment engagement.

Treatment must not reproduce the stigma contributing to the problem.

Anxiety

53. Anxiety and Obesity Are Also Associated

The source characterises the overall association as positive but relatively weak, with stronger associations in severe obesity.

54. Social Anxiety May Be Particularly Relevant

Weight-related stigma, shame and fear of judgement may contribute to social avoidance.

55. Stress Physiology May Provide Another Connection

The:

HYPOTHALAMIC–PITUITARY–ADRENAL AXIS

may link chronic anxiety and stress with eating and metabolic processes.

Severe Mental Illness

56. Obesity Is Particularly Important in Severe Mental Illness

The source reports rates as high as approximately:

60%

among populations with conditions such as schizophrenia and bipolar disorder.

57. Medication Is Only Part of the Explanation

Obesity can also occur in medication-naïve patients.

Therefore the relationship cannot be attributed entirely to psychotropics.

58. Physical Health Consequences Are Particularly Serious

Patients with severe mental illness have increased risk of:

* diabetes

* cardiovascular disease

* metabolic syndrome

* premature mortality.

Psychotropic Medication

59. Psychiatrists Must Think Metabolically

Every prescription involves a balance between:

PSYCHIATRIC BENEFIT

and

PHYSICAL CONSEQUENCES

60. Antipsychotics Can Cause Substantial Weight Gain

The source identifies particularly high weight-gain profiles for:

OLANZAPINE

CLOZAPINE

and

QUETIAPINE

61. Risperidone Has an Intermediate Profile in the Source

Other agents are described as having lower or more neutral profiles.

62. Antidepressants Differ in Their Weight Effects

The chapter describes:

MIRTAZAPINE → weight gain

and

BUPROPION → potential weight loss

with considerable variation across antidepressants.

63. TCAs and MAOIs Tend to Produce More Weight Gain Than SSRIs

Medication selection should therefore consider metabolic health where clinically appropriate.

64. Mood Stabilisers Also Differ

The source associates greater weight gain with:

* lithium

* divalproex

* carbamazepine.

65. Lamotrigine Is Relatively Weight-Neutral

The table identifies it as:

0 - weight neutral

66. Topiramate and Zonisamide Are Associated With Weight Loss

The table marks both with a negative weight-change profile.

67. Weight Gain Can Reduce Medication Adherence

A patient may stop an otherwise effective medication because of its metabolic consequences.

Therefore discussing weight effects before prescribing matters.

68. Monitor Metabolic Health

For patients at risk, monitoring may include:

* weight

* BMI

* waist circumference

* blood pressure

* glucose

* lipids.

69. Prevention Should Begin With the Prescription

Do not wait for substantial weight gain before discussing:

* diet

* activity

* metabolic monitoring

* behavioural strategies.

Treatment

70. Obesity Treatment Should Be Individualised

The central foundation is:

BEHAVIOURAL + DIETARY + PHYSICAL ACTIVITY INTERVENTION

with medication or surgery added when indicated.

71. Modest Weight Loss Can Be Clinically Meaningful

Approximately:

5–10%

weight reduction can produce meaningful improvements in health measures.

72. Even Smaller Changes May Help

The chapter reports metabolic benefits with reductions around:

3%

of body weight.

73. The Goal Does Not Need to Be “Ideal Weight”

A clinically meaningful goal can be:

SMALLER + SUSTAINABLE + HEALTH-PROMOTING

rather than dramatic.

Diet

74. Many Dietary Approaches Can Produce Weight Loss

The chapter discusses:

* low-calorie diets

* very-low-calorie diets

* low-carbohydrate approaches

* structured commercial programmes.

75. No Single Diet Consistently Dominates

Differences between dietary approaches are often smaller than expected.

76. Adherence Is a Major Predictor of Outcome

A theoretically excellent diet that cannot be sustained is unlikely to produce lasting benefit.

Therefore:

SUSTAINABILITY > PERFECT DIET

Behavioural Weight Management

77. Behavioural Weight Loss Is Based on Learning Principles

Change the environment and contingencies surrounding behaviour, and behaviour itself becomes easier to change.

78. Core Behavioural Strategies Include

* psychoeducation

* self-monitoring

* goal setting

* stimulus control

* problem-solving

* dietary modification

* increased physical activity.

79. Self-Monitoring Is Particularly Important

Monitoring can include:

* food intake

* activity

* weight

* triggers

* progress towards goals.

80. Consistency May Matter More Than Exhaustive Detail

The chapter reports that frequent and consistent dietary self-monitoring predicted maintenance better than simply making records more comprehensive.

81. Stimulus Control Changes the Environment

Instead of relying solely on willpower, alter the cues.

For example:

TRIGGER FOOD READILY AVAILABLE

becomes

TRIGGER FOOD LESS ACCESSIBLE

82. Behavioural Programmes Produce Meaningful Initial Weight Loss

The source reports typical reductions of approximately:

5–10% OVER 6 MONTHS

Maintenance

83. Losing Weight and Maintaining Weight Are Different Problems

This is one of the chapter’s most important concepts.

84. Weight Regain Is Common

Long-term maintenance is substantially more difficult than initial weight reduction.

85. Maintenance Requires Continuing Behaviour

Successful maintainers tend to demonstrate:

* continued physical activity

* dietary awareness

* behavioural strategies

* regular self-monitoring.

86. Relapse Should Be Expected Rather Than Moralised

A setback does not prove that treatment has failed.

It means the maintenance system needs to be examined.

Cognitive Behavioural Therapy

87. CBT Adds Cognitive Work to Behavioural Weight Management

It targets:

THOUGHTS + EMOTIONS + BEHAVIOURS + ENVIRONMENT

88. All-or-Nothing Thinking Can Trigger Relapse

For example:

“I ate one biscuit.”

↓

“I’ve ruined the diet.”

↓

“I may as well eat the whole packet.”

The first biscuit is not necessarily the problem.

The interpretation of it may be.

89. Cognitive Restructuring Challenges These Thoughts

Ask:

* What is the evidence?

* Is this all-or-nothing thinking?

* Does one lapse erase previous progress?

* What alternative interpretation would help?

90. Behavioural Experiments Test Beliefs

For example:

“I’m too tired to exercise after work.”

can become an experiment:

“Take a short walk and observe what actually happens.”

91. Stress Management Can Reduce Emotional Eating

Strategies include:

* guided imagery

* diaphragmatic breathing

* progressive muscle relaxation.

ACT and Mindfulness

92. Acceptance-Based Treatment Targets Experiential Avoidance

Instead of:

UNPLEASANT FEELING → MUST GET RID OF IT → EAT

the person learns:

UNPLEASANT FEELING → NOTICE IT → ALLOW IT → CHOOSE ACTION

93. ACT Does Not Require Cravings to Disappear

The goal is increased:

PSYCHOLOGICAL FLEXIBILITY

94. Values Provide Direction

The question becomes:

“What behaviour serves the life I want?”

rather than:

“How do I make this uncomfortable feeling disappear immediately?”

Readiness to Change

95. Behaviour Change Occurs in Stages

The source describes:

PRECONTEMPLATION

→ CONTEMPLATION

→ PREPARATION

→ ACTION

→ MAINTENANCE

→ TERMINATION

96. Change Is Usually a Spiral, Not a Straight Line

People may move forward, relapse, return to an earlier stage and then progress again.

97. Treatment Should Match the Stage

Giving action-oriented homework to somebody in contemplation may produce resistance or dropout.

98. Motivational Interviewing Helps Resolve Ambivalence

Core principles include:

* empathy

* collaboration

* developing discrepancy

* supporting self-efficacy

* exploring ambivalence

* reinforcing autonomy.

99. MI Asks Rather Than Commands

Instead of:

“YOU NEED TO LOSE WEIGHT.”

the clinician helps the patient explore:

“WHAT MATTERS TO YOU, AND WHAT CHANGE ARE YOU READY TO MAKE?”

Medical and Surgical Treatment

100. Medication Can Be Added to Lifestyle Intervention

The chapter discusses pharmacological treatment for appropriate patients alongside diet, activity and behavioural management.

101. The Source Discusses Several Weight-Loss Medicines

These include:

* orlistat

* phentermine/topiramate

* naltrexone/bupropion

* phentermine

* liraglutide.

Because obesity pharmacotherapy has evolved rapidly, the chapter’s medication list should be understood in the context of when the source was written rather than as a current prescribing guideline.

102. GLP-1 Signalling Is Particularly Important

The source discusses liraglutide acting through GLP-1 pathways involved in appetite regulation and notes promising evidence emerging for the GLP-1 agonist class.

103. Medication Does Not Eliminate the Maintenance Problem

Weight regain can occur when pharmacotherapy is discontinued.

Obesity therefore often requires ongoing management.

Bariatric Surgery

104. Surgery Is the Most Effective Long-Term Treatment Described for Severe Obesity

The source considers candidates including:

BMI >40

or

BMI >35 + obesity-related disease

within the criteria used in the chapter.

105. Bariatric Procedures Work Through Different Mechanisms

The diagram on page 37 illustrates:

GASTRIC BAND

SLEEVE GASTRECTOMY

ROUX-EN-Y GASTRIC BYPASS

BILIOPANCREATIC DIVERSION

and demonstrates the distinction between restrictive and malabsorptive approaches.

106. Surgery Can Produce Major Medical Benefits

Potential improvements include:

* metabolic syndrome

* hypertension

* sleep apnoea

* fatty liver disease

* hypercholesterolaemia

* reflux

* quality of life.

107. Psychological Assessment Is Part of Bariatric Care

Assessment should explore:

* motivation

* expectations

* understanding of surgery

* ability to make lifestyle changes

* psychiatric symptoms

* substance use

* eating behaviour

* social support

* coping strategies.

108. Psychiatric Instability May Need Treatment Before Surgery

The source identifies concerns such as:

* unstable depression

* psychosis

* suicidal ideation

* active bulimia

* active substance misuse.

The aim is optimisation and safety rather than simply excluding people because they have a psychiatric diagnosis.

109. Surgery Does Not End the Need for Mental Healthcare

Postoperative issues may include:

* mood symptoms

* changing relationships

* body-image adjustment

* excess skin

* recurrence of disordered eating

* substance use

* medication absorption changes.

110. Alcohol Problems Require Particular Attention After Bariatric Surgery

The source describes increased risk of alcohol-use disorders following some procedures.

111. Suicide Risk Also Requires Monitoring

The chapter reports increased suicide risk after bariatric surgery, reinforcing the importance of longitudinal psychiatric follow-up.

112. Psychotropic Pharmacokinetics May Change

For example, absorption of some antidepressants may change following Roux-en-Y gastric bypass.

Medication response therefore requires reassessment after surgery.

The Central Clinical Framework

113. Never Reduce Obesity to Willpower

The clinically useful question is not:

“Why can’t this person just eat less?”

Ask instead:

What biological, psychological, environmental and behavioural mechanisms are maintaining the current pattern?

114. Assess the Biological System

Consider:

* genetics

* metabolic health

* appetite

* sleep

* medications

* physical illness

* mobility.

115. Assess Eating Behaviour

Look for:

* hunger-driven eating

* emotional eating

* binge eating

* grazing

* night eating

* loss of control

* food cues.

116. Assess Mental Health

Consider:

* depression

* anxiety

* trauma

* severe mental illness

* body image

* stigma

* substance use.

117. Assess the Environment

Ask about:

* food availability

* work

* activity opportunities

* finances

* social environment

* routine

* environmental triggers.

118. Assess Medication

Particularly ask:

IS THE TREATMENT OF THE PSYCHIATRIC DISORDER CONTRIBUTING TO THE METABOLIC PROBLEM?

119. Assess Readiness

Before prescribing behaviour change, determine whether the person is:

CONTEMPLATING

PREPARING

or already

ACTING.

120. The Central Principle

The simplistic model is:

EAT TOO MUCH → EXERCISE TOO LITTLE → OBESITY

Holmes’s model is:

GENETICS

↓

BIOLOGY ↔ ENVIRONMENT

↓

REWARD ↔ EMOTION ↔ EATING

↓

ACTIVITY ↔ MEDICATION ↔ METABOLISM

↓

WEIGHT

↓

PHYSICAL HEALTH ↔ MENTAL HEALTH ↔ STIGMA

↓

FUTURE BEHAVIOUR

Treatment therefore needs to move from:

BLAME → UNDERSTANDING

EXTREME GOALS → SUSTAINABLE CHANGE

WILLPOWER → SYSTEM DESIGN

SHORT-TERM LOSS → LONG-TERM MAINTENANCE

and ultimately:

WEIGHT MANAGEMENT → WHOLE-PERSON HEALTH

and the extraordinary bidirectional conversation of the brain–gut–microbiome axis.

Medlock Holmes enters The Great Gut–Brain Exchange, an immense Neo-Victorian communication network in which the brain and gastrointestinal tract are joined by constantly moving signals. Messages travel downward through the autonomic nervous system, HPA axis and neuroendocrine pathways, while sensory, immune, hormonal and microbial signals travel back towards the brain.

There is no single direction of causation.

Instead:

BRAIN ↔ GUT ↔ IMMUNE SYSTEM ↔ MICROBIOME

This brain–gut–microbiome axis provides the central framework for understanding why gastrointestinal illness and psychiatric symptoms so frequently coexist. Biological, psychological and social influences are not competing explanations; they are interacting parts of the same system.

Holmes first investigates inflammatory bowel disease, principally Crohn disease and ulcerative colitis. These are inflammatory diseases, yet their consequences extend far beyond the bowel. Depression and anxiety are common, particularly when disease is active, while pain, fatigue, cognitive difficulties, insomnia, fear of incontinence and the experience of repeated hospitalisation or surgery can profoundly affect psychological wellbeing. The relationship may also operate in the opposite direction, with psychological distress influencing symptom experience, self-management and potentially disease outcomes.

Treatment itself can create psychiatric complications. One chamber contains a particularly important clue: corticosteroids. A patient being treated successfully for severe inflammatory bowel disease may develop agitation, confusion, suspiciousness or psychosis. The psychiatrist must therefore investigate not merely the disease but also what has been done to treat it.

Holmes then enters the much larger and more complicated territory of functional gastrointestinal disorders, now commonly conceptualised as disorders of gut–brain interaction. Here, symptoms are genuine even when conventional structural investigations are normal.

The most familiar example is irritable bowel syndrome. Recurrent abdominal pain interacts with defecation and changes in stool frequency or form. But beneath the symptoms Holmes finds multiple mechanisms: altered motility, visceral hypersensitivity, stress-system dysregulation, immune activity, early-life experiences and altered central processing.

Further along lies centrally mediated abdominal pain syndrome, where abdominal pain becomes continuous or nearly continuous and substantially disrupts daily life despite the absence of another condition adequately explaining it.

Another corridor leads to functional chest pain, where recurrent retrosternal pain persists after appropriate cardiac, oesophageal and reflux pathology has been excluded. Here again, hypersensitivity, hypervigilance, autonomic arousal and altered central processing may amplify the experience of bodily signals.

One of the most dangerous traps in this entire hall is written above a doorway:

“THE TESTS ARE NORMAL, SO IT MUST BE IN YOUR HEAD.”

Holmes refuses to enter.

Functional symptoms are not imaginary symptoms.

Instead, the clinical task is to explain how altered sensation, processing, attention, stress physiology and gut–brain communication can produce genuine suffering without requiring visible structural damage.

The psychiatrist therefore becomes neither the clinician who proves that “nothing is wrong” nor the final destination after medicine has failed. Psychiatry becomes part of integrated gastrointestinal care.

The tools are familiar - antidepressants, CBT, mindfulness, relaxation, interpersonal approaches, psychodynamic therapy, hypnotherapy and selected neuromodulators - but the therapeutic relationship may be just as important.

The investigation ultimately leads Holmes to a deceptively simple principle:

Validate the symptom. Explain the mechanism. Reduce unnecessary investigation. Treat psychiatric comorbidity. Restore function.

The gut and brain are not separate suspects.

They are partners in the same conversation.

Key Takeaways

1. The Gut and Brain Communicate Bidirectionally

The central concept is:

BRAIN ↔ GUT

Neither organ simply acts upon the other.

2. The Modern Model Goes Beyond the Gut–Brain Axis

The broader construct is the:

BRAIN–GUT–MICROBIOME AXIS

It incorporates interactions involving:

* CNS

* enteric nervous system

* autonomic nervous system

* HPA axis

* immune system

* endocrine signalling

* intestinal microbiome.

3. Communication Occurs Through Multiple Pathways

Think:

NEURAL + IMMUNE + HORMONAL + MICROBIAL

These pathways interact continuously.

4. The Biopsychosocial Model Is Particularly Appropriate for GI Disorders

Biological, psychological and social influences should not be considered competing explanations.

They interact.

5. The Organic–Functional Divide Has Limitations

Historically, disorders have been divided into:

ORGANIC = identifiable structural/biochemical abnormality

versus

FUNCTIONAL = symptoms without such abnormalities

But this distinction can be misleading.

6. Peptic Ulcer Disease Provides a Historical Warning

Peptic ulcer disease was once considered strongly psychosomatic before the importance of Helicobacter pylori was recognised.

Therefore:

“WE CANNOT SEE THE MECHANISM” ≠ “THERE IS NO MECHANISM.”

7. Organic and Functional Disease Can Coexist

A patient with inflammatory bowel disease can achieve mucosal healing and still experience significant functional gastrointestinal symptoms.

One diagnosis does not exclude the other.

Inflammatory Bowel Disease

8. The Two Major Forms of IBD Are

CROHN DISEASE

and

ULCERATIVE COLITIS

9. Crohn Disease Can Affect the Entire GI Tract

It may involve anywhere from:

MOUTH → ANUS

10. Ulcerative Colitis Is Confined to the Colon

This provides an important distinction from Crohn disease.

11. IBD Is an Inflammatory Disorder

The chapter conceptualises its pathogenesis as an interaction between:

GENETIC SUSCEPTIBILITY

MICROBIOME

INAPPROPRIATE IMMUNE RESPONSE

12. IBD Symptoms Extend Beyond Diarrhoea

Patients may experience:

* abdominal pain

* diarrhoea

* rectal bleeding

* fatigue

* malnutrition

* weight loss

* anaemia

* joint symptoms

* skin manifestations.

13. IBD Can Profoundly Affect Quality of Life

The burden comes not merely from intestinal inflammation but also:

* fatigue

* cognitive symptoms

* extraintestinal manifestations

* treatment burden

* psychological consequences.

14. Depression and Anxiety Are Common in IBD

Mood disorders may affect as many as approximately:

1 IN 3

patients with IBD.

15. Psychiatric Symptoms Often Increase During IBD Relapse

Anxiety and depression tend to be particularly prominent in:

SEVERE

and

ACTIVE

IBD.

16. Depression and IBD May Have a Bidirectional Relationship

The model is not simply:

IBD → DEPRESSION

It may involve:

IBD ↔ DEPRESSION

17. Psychiatric Comorbidity Can Affect Symptom Experience

Depression and anxiety may contribute to:

* visceral hypersensitivity

* increased bowel symptom burden

* fatigue

* insomnia

* cognitive problems

* impaired coping.

18. Visceral Hypersensitivity Is a Key Concept

The gastrointestinal system can become unusually sensitive to internal stimuli.

Signals that might normally produce little discomfort can be experienced as significant pain.

19. IBD Can Be Associated With Cognitive Difficulties

Reported problems include impairment in:

* processing speed

* short-term memory

* aspects of verbal functioning.

Systemic inflammation may contribute.

20. Anxiety in IBD Can Become Highly Symptom-Specific

Patients may develop fear of:

* nausea

* vomiting

* eating

* diarrhoea

* faecal incontinence.

21. Fear of Incontinence Can Produce Avoidance

A patient may begin avoiding:

* public transport

* unfamiliar locations

* queues

* social activities

* places without immediately accessible toilets.

This can resemble or contribute to agoraphobic behaviour.

22. PTSD Can Occur in IBD

Potential traumatic experiences include:

* severe disease

* repeated hospitalisation

* invasive procedures

* surgery

* frightening exacerbations.

Treatment and IBD

23. Treating Depression Can Improve More Than Mood

Effective treatment may improve:

* self-management

* relationships

* social support

* engagement with treatment teams

* quality of life.

The source also describes associations with improved IBD outcomes.

24. Psychological Treatments Have a Role

Approaches discussed include:

* CBT

* supportive therapy

* relaxation

* mindfulness

* gut-directed hypnotherapy.

25. Psychotropics Can Be Chosen According to the Clinical Problem

For example:

MIRTAZAPINEmay be useful where nausea, poor appetite or weight difficulties are prominent.

TCAsmay target pain, visceral hypersensitivity, IBS symptoms and insomnia.

SNRIsmay help depression, anxiety and chronic pain.

Steroid-Induced Psychiatric Illness

26. Corticosteroids Can Produce Psychiatric Adverse Effects

These may include:

* anxiety

* agitation

* mood disturbance

* confusion

* psychosis.

27. Always Review Medication When Mental State Suddenly Changes

In someone receiving treatment for a physical illness:

NEW PSYCHIATRIC SYMPTOMS → REVIEW NEW MEDICATIONS

before assuming a primary psychiatric disorder.

28. The Chapter’s Clinical Case Demonstrates This Clearly

A woman receiving intravenous hydrocortisone for severe ulcerative colitis developed:

CONFUSION → AGITATION → ANXIETY → PARANOIA

and was diagnosed with steroid-induced psychosis.

The colonoscopy image on page 8 shows markedly inflamed, friable and ulcerated rectal mucosa, emphasising that the patient had severe genuine inflammatory disease at the same time as a treatment-induced psychiatric complication.

Functional Gastrointestinal Disorders

29. Functional GI Symptoms Are Real Symptoms

The absence of a visible structural lesion does not make symptoms imaginary.

This principle is fundamental.

30. Functional GI Disorders Are Common

More than 25 separate disorders have been described within this broad category.

31. IBS Is the Most Prevalent Functional GI Disorder

The chapter reports a global prevalence exceeding:

10%

with a female predominance.

Irritable Bowel Syndrome

32. The Core Symptom of IBS Is Recurrent Abdominal Pain

The Rome IV framework links pain to bowel function.

33. Rome IV Requires Recurrent Abdominal Pain

The chapter’s table on page 10 specifies pain on average at least:

1 DAY PER WEEK

during the previous 3 months.

34. The Pain Must Be Associated With at Least Two Features

* related to defecation

* change in stool frequency

* change in stool form.

Symptoms should have begun at least 6 months before diagnosis.

35. IBS Can Be Classified by Predominant Stool Pattern

The figure on page 10 divides IBS into:

IBS-C - constipation predominant

IBS-D - diarrhoea predominant

IBS-M - mixed bowel habits

IBS-U - unclassified.

36. IBS Is Not Only About the Bowel

Associated symptoms may include:

* fatigue

* headache

* dysmenorrhoea

* dyspareunia.

37. Psychiatric Comorbidity Is Very Common in IBS

Important associations include:

* major depression

* panic disorder

* generalised anxiety disorder

* PTSD

* somatic symptom disorder.

38. More Than Half of Patients With IBS May Have Psychiatric Comorbidity

The chapter reports that psychiatric disorders occur in over half of patients in some samples.

39. IBS and Psychiatric Illness Are Again Bidirectional

Think:

DISTRESS ↔ GI SYMPTOMS

Psychological distress can influence bowel symptoms.

Chronic bowel symptoms can produce psychological distress.

40. Early-Life Experiences May Be Relevant

The source discusses associations between later visceral sensitivity and:

* adverse early-life experiences

* childhood sexual abuse

* other significant stressors.

These are risk factors and associations, not simple deterministic causes.

41. Multiple Mechanisms May Contribute to IBS

These include:

* brain–gut dysregulation

* HPA-axis dysregulation

* altered GI motility

* visceral hypersensitivity

* immune reactivity

* infection

* genetic susceptibility

* psychosocial factors.

Centrally Mediated Abdominal Pain Syndrome

42. CAPS Is Dominated by Pain

The core presentation is:

CONTINUOUS OR NEARLY CONTINUOUS ABDOMINAL PAIN

with significant interference in everyday functioning.

43. CAPS Differs From IBS

In IBS, pain is related to bowel function.

In CAPS, pain has:

NO OR ONLY OCCASIONAL RELATIONSHIP

to physiological events such as:

* eating

* defecation

* menstruation.

44. CAPS Must Impair Function

This may affect:

* work

* education

* relationships

* intimacy

* social activity

* leisure

* caregiving.

45. The Pain Is Not Feigned

This is explicitly part of the Rome IV criteria described in the chapter.

That distinction is essential.

46. Other Explanations Must Be Considered

The pain should not be better explained by another:

* structural GI disorder

* functional GI disorder

* medical condition.

47. Central Pain Processing Appears Important

The chapter describes alterations involving areas including:

* somatosensory cortex

* insula

* anterior cingulate cortex.

48. Functional Disorders Often Cluster

A patient with chronic functional abdominal pain may also have:

* fibromyalgia

* chronic fatigue

* generalised pain

* other functional symptoms.

The Investigation Cycle

49. Repeated Negative Investigations Can Become Part of the Problem

The patient may move through:

SYMPTOMS

→ INVESTIGATION

→ NORMAL RESULT

→ CONTINUING UNCERTAINTY

→ ANOTHER DOCTOR

→ MORE INVESTIGATIONS

→ MORE ANXIETY

→ MORE SYMPTOMS

50. The Chapter Illustrates This Cycle Directly

The diagram on page 16 shows:

CHRONIC UNEXPLAINED SYMPTOMS

→ DISENFRANCHISED PATIENT

→ MULTIPLE INVESTIGATIONS

→ POOR TREATMENT OUTCOMES

→ MULTIPLE DIFFERENT PHYSICIANS

→ back to chronic unexplained symptoms.

51. More Testing Is Not Always More Reassuring

Repeated investigations may inadvertently communicate:

“WE STILL THINK SOMETHING DANGEROUS HAS BEEN MISSED.”

This can reinforce fear and symptom vigilance.

52. The Cycle Can Be Interrupted

The chapter emphasises:

TIME + EMPATHY + VALIDATION

Functional Chest Pain

53. Functional Chest Pain Is Recurrent Retrosternal Pain

It occurs without an adequate structural explanation after appropriate investigation.

54. Appropriate Exclusions Are Important

The source describes excluding:

* GERD

* eosinophilic oesophagitis

* major oesophageal motor disorders.

Investigations may include:

* upper endoscopy

* biopsy

* reflux testing

* oesophageal manometry.

55. Functional Chest Pain Is Not a Diagnosis Made by Ignoring Cardiac Disease

Potentially dangerous cardiac explanations must first be considered appropriately.

56. Oesophageal Hypersensitivity May Contribute

Mechanical or chemical stimuli may be experienced more intensely than expected.

57. Stress Systems May Amplify Symptoms

Relevant systems include:

ANS

and

HPA AXIS

58. Central Processing Also Matters

The brain’s interpretation of oesophageal sensory input can influence the intensity of the experienced symptom.

59. Psychological Comorbidity Is Common

The chapter reports psychological comorbidity in up to:

61%

of patients with functional chest pain.

Presentation Bias

60. Depression Does Not Always Present as “I Feel Depressed”

Patients may present with:

* abdominal pain

* nausea

* fatigue

* bowel disturbance

* sleep problems

* multiple physical complaints.

61. This Can Produce “Presentation Bias”

When the patient’s presentation is predominantly physical, clinicians may fail to recognise underlying:

DEPRESSION

or

ANXIETY

62. The More Physical Symptoms, the Greater the Probability of Psychological Distress

The table on page 20 shows a striking gradient:

Number of physical symptoms

Mood or anxiety disorder

0–1

4%

2–3

18%

4–5

31%

6–8

52%

9+

78%

This does not mean multiple symptoms are “psychological”; it means increasing somatic symptom burden should also prompt thoughtful assessment of emotional distress.

The Gut–Brain Axis

63. Stress Can Influence GI Physiology

Stress can alter:

* motility

* pain thresholds

* inflammation

* autonomic activity

* HPA-axis activity.

64. The Gut Can Influence the Brain

Signals originating in the gastrointestinal tract can influence:

* arousal

* emotion

* vigilance

* pain processing

* anxiety.

65. The Diagram on Page 23 Captures the Central Model

External and internal stressors influence the brain and neuroendocrine response.

Signals then interact with:

HPA AXIS

AUTONOMIC NERVOUS SYSTEM

SENSORY MODULATION

and the:

GASTROINTESTINAL TRACT

Feedback then returns towards the CNS.

The essential message is:

BIDIRECTIONAL COMMUNICATION

Visceral Sensitisation

66. Both Peripheral and Central Factors Can Increase Symptom Burden

Peripheral factors include:

* hormones

* injury

* infection

* diet.

Central or psychosocial influences include:

* chronic stress

* coping difficulties

* psychiatric illness

* adverse experiences.

67. The Figure on Page 25 Shows Two Routes Towards Greater Symptom Burden

One involves increased:

AFFERENT NERVE EXCITATION

The other involves reduced:

AFFERENT NERVE INHIBITION

Both can move the person from mild towards severe symptoms.

Therapeutic Relationship

68. The Therapeutic Relationship Is Part of Treatment

The psychiatrist should:

* elicit beliefs

* understand concerns

* explore expectations

* demonstrate empathy

* correct misunderstandings

* provide education

* negotiate treatment collaboratively.

69. Validate Before Reframing

A useful sequence is:

LISTEN → VALIDATE → EXPLAIN → CONNECT → TREAT

not:

NORMAL TEST → PSYCHIATRIC REFERRAL

70. Never Communicate “It’s All in Your Head”

That framing:

* invalidates the patient

* misunderstands functional illness

* damages trust

* increases stigma

* can make psychiatric referral harder.

71. Psychiatry Should Not Represent Rejection From Gastroenterology

The message should instead be:

“We understand your symptoms better when we treat the gut and brain together.”

72. Symptom Diaries Can Be Useful

Patients can record:

* pain

* bowel movements

* stool consistency

* menstruation

* diet

* lifestyle

* stressors.

This can reveal patterns and create opportunities for psychoeducation and CBT.

Chronic Illness

73. Cure Is Not Always the Immediate Goal

For chronic functional symptoms, a more realistic goal may be:

BETTER FUNCTION DESPITE SYMPTOMS

74. Excessive Diagnostic Investigation Can Be Harmful

Once an adequate diagnostic assessment has been completed, repeated investigations may:

* reinforce fear

* expose patients to procedural risk

* increase healthcare dependence

* perpetuate uncertainty.

75. Health-Promoting Behaviour Should Be Reinforced

The focus gradually shifts from:

“FIND THE HIDDEN DISEASE”

towards:

“RESTORE LIFE AND FUNCTION.”

Psychopharmacology

76. Antidepressants Can Help FGIDs Even Without Major Depression

This is an important concept.

They may function as:

NEUROMODULATORS

rather than merely “antidepressants”.

77. Their Effects Can Occur Throughout the Gut–Brain Axis

Relevant neurotransmitters include:

* serotonin

* noradrenaline

* CRF

* endogenous opioid pathways.

78. TCAs Can Help Chronic Visceral Pain

Potential benefits include:

* central pain modulation

* peripheral effects

* slowing gastrointestinal transit.

79. One Detail in the Source Requires Careful Reading

The chapter states that slowing GI transit may be valuable for IBS-C, but later recommends TCAs particularly where diarrhoea predominates. Physiologically, slowing transit aligns more naturally with diarrhoea-predominant symptoms.

For the podcast, the important source-supported principle is:

TCAs CAN MODULATE PAIN AND SLOW GI TRANSIT.

80. SSRIs Have Different GI Effects

SSRIs can stimulate gastrointestinal motility.

They may therefore be particularly useful where:

* anxiety

* phobic symptoms

* somatisation

* constipation

are prominent.

81. SNRIs Can Be Useful for Pain

Their combined serotonergic and noradrenergic activity makes them relevant where:

PAIN + ANXIETY/DEPRESSION

coexist.

82. Mirtazapine Has a Useful GI Profile

It may be particularly helpful when the clinical picture includes:

* nausea

* reduced appetite

* weight loss

* insomnia.

83. The Chapter Reports a Low NNT for Antidepressants in IBS

The reported:

NNT ≈ 3.2

for overall improvement illustrates why psychotropics may be useful beyond treating formal psychiatric diagnoses.

84. Benzodiazepines Have a Limited Long-Term Role

They may reduce acute anxiety but chronic use is limited by:

* sedation

* cognitive effects

* tolerance

* dependence

* addiction risk.

FGIDs are usually chronic disorders, making long-term benzodiazepines particularly problematic.

Psychological Treatment

85. There Is No Single Best Psychological Therapy for Every Patient

Treatment should be matched to:

* formulation

* symptoms

* psychiatric comorbidity

* preferences

* motivation

* availability.

86. Engagement Is Fundamental

Even an effective therapy is unlikely to work if the patient experiences referral as:

“The doctors have given up and think I’m imagining this.”

87. Relaxation Therapy Targets Physiological Arousal

Approaches include:

* progressive muscle relaxation

* biofeedback

* autogenic training

* mindfulness

* meditation.

88. CBT Is One of the Best-Studied Approaches

CBT helps patients identify relationships between:

SITUATION → THOUGHT → EMOTION → PHYSIOLOGY → BEHAVIOUR → SYMPTOM

89. CBT Does Not Mean “Think Positively and the Pain Will Disappear”

Instead, it targets processes such as:

* catastrophising

* hypervigilance

* avoidance

* maladaptive interpretations

* coping behaviours.

90. CBT Can Increase Autonomy

The aim is to move from:

SYMPTOM → FEAR → HELPLESSNESS

towards:

SYMPTOM → UNDERSTANDING → STRATEGY → CONTROL

91. Mindfulness-Based Approaches May Also Help

The chapter describes improvements in:

* symptom severity

* quality of life

* visceral sensitivity.

92. Interpersonal Therapy Looks at Relationship Context

Important areas include:

* grief

* role transitions

* interpersonal conflict

* relationship difficulties.

These may influence physiological arousal and symptom experience.

93. Psychodynamic Therapy May Be Useful in Selected Patients

It explores relationships between:

* symptoms

* emotions

* relationships

* losses

* earlier experiences.

The chapter reports an estimated:

NNT ≈ 4

although treatment selection remains individualised.

94. Gut-Directed Hypnotherapy Has Evidence

Hypnosis combines:

* relaxation

* focused attention

* suggestion

* modulation of symptom perception.

The ultimate aim is increased self-regulation rather than dependence on the therapist.

95. Biofeedback Makes Physiology Visible

Patients receive information about physiological processes and learn to modify them.

It has particular applications in:

* constipation

* incontinence

* pelvic-floor dysfunction

* stress regulation.

The Psychiatrist’s Role

96. The Psychiatrist Is Not Merely Treating Comorbidity

The psychiatrist may contribute directly to management of:

* visceral pain

* hypervigilance

* autonomic arousal

* catastrophising

* coping

* adherence

* illness behaviour

* psychiatric comorbidity.

97. Multidisciplinary Care Is Often Best

The team may include:

GASTROENTEROLOGIST

PRIMARY CARE

PSYCHIATRIST

PSYCHOLOGIST/THERAPIST

DIETITIAN/NUTRITIONIST

98. The Most Important Clinical Error Is False Dualism

Avoid:

ORGANIC OR PSYCHOLOGICAL

Instead think:

BIOLOGICAL + PSYCHOLOGICAL + SOCIAL

99. Holmes’s Clinical Framework

When confronted with chronic gastrointestinal symptoms, ask:

1. Is there an organic gastrointestinal disease?

2. Has appropriate investigation been completed?

3. Is there a disorder of gut–brain interaction?

4. Is visceral hypersensitivity present?

5. What is the patient’s understanding of the symptoms?

6. Are anxiety, depression, trauma or other psychiatric disorders present?

7. Are medications contributing to symptoms?

8. Are repeated investigations perpetuating fear?

9. What maintains the symptom cycle?

10. How can treatment restore function and autonomy?

100. The Central Principle

The old model says:

NORMAL TESTS → NOTHING WRONG → PSYCHOLOGICAL

The modern model says:

GUT ↔ BRAIN ↔ IMMUNE SYSTEM ↔ MICROBIOME ↔ EXPERIENCE

Symptoms emerge from the interaction of these systems.

The task is therefore not to decide whether suffering is “physical” or “psychological.”

It is to understand the system producing it - and help the patient regain control.

Medlock Holmes enters The Engine Room of the Heart, where an enormous mechanical heart is connected to the brain by networks carrying stress, emotion, behaviour, autonomic signals and medication effects.

The relationship is strikingly bidirectional. Cardiovascular disease can produce anxiety, depression, cognitive disturbance and trauma-related symptoms, while psychiatric disorders and psychological stress can influence cardiovascular risk, recovery and mortality. Behaviour provides another bridge: smoking, inactivity, poor diet and reduced adherence can all become more prominent during psychiatric illness. Cardiovascular disease remains a major cause of death and disability, making these interactions clinically important.

Holmes begins with coronary artery disease (CAD). Depression is strongly associated with both the development and progression of CAD, with behavioural pathways such as smoking, inactivity and poor adherence interacting with possible biological pathways involving autonomic function, the HPA axis, endothelial function and platelet activation. Anxiety, PTSD, chronic stress and low social support also enter the investigation.

The relationship becomes especially important in severe mental illness. People with schizophrenia, schizoaffective disorder and bipolar disorder experience substantial cardiovascular morbidity through overlapping influences: smoking, sedentary behaviour, reduced access to healthcare, metabolic illness and the cardiometabolic effects of some psychotropic medications.

Holmes then enters the chambers of heart failure, transplantation and ventricular assist devices, where psychiatric assessment becomes part of complex cardiovascular treatment. Depression, anxiety, cognition, substance use, adherence, social support and decision-making capacity may all influence care.

But another mystery emerges: sometimes the heart masquerades as the mind. Arrhythmias, syncope and pulmonary thromboembolism can resemble panic or functional symptoms. Conversely, panic disorder, anxiety and somatic symptom disorder can produce chest pain and palpitations that resemble cardiac disease.

The ECG therefore becomes part of the psychiatrist’s toolkit. Psychotropic medications can affect heart rate, conduction, blood pressure and ventricular repolarisation. Holmes pays particular attention to QTc prolongation and torsades de pointes, recognising that risk depends not simply on one medication but on the combination of drug, dose, cardiac disease, age, sex, renal or hepatic dysfunction, electrolyte abnormalities, bradycardia and interacting medications.

By the end, Holmes realises that the heart is neither simply a mechanical pump nor a metaphor for emotion.

It is an organ profoundly influenced by brain, behaviour, environment, illness and treatment.

Key Takeaways

1. Cardiovascular Disease and Psychiatry Have a Two-Way Relationship

The central framework is:

PSYCHIATRIC ILLNESS → CARDIOVASCULAR RISK

and

CARDIOVASCULAR ILLNESS → PSYCHIATRIC CONSEQUENCES

Psychiatric treatment itself can also affect cardiovascular physiology.

2. Major Cardiovascular Conditions Relevant to Psychiatry Include

* coronary artery disease

* hypertension

* myocardial infarction

* heart failure

* cardiomyopathy

* valvular disease

* arrhythmias

* conduction disorders

* cardiac transplantation

* ventricular assist devices.

3. Coronary Artery Disease Is an Atherosclerotic Process

Atherosclerotic plaques develop within coronary arteries.

Plaque disruption can produce:

PLAQUE RUPTURE → THROMBUS → CORONARY OCCLUSION → ISCHAEMIA → MYOCARDIAL INJURY

Acute coronary syndromes include unstable angina, myocardial infarction and cardiac arrest.

4. Traditional CAD Risk Factors Remain Fundamental

Important factors include:

* family history

* male sex

* hypertension

* hyperlipidaemia

* diabetes

* obesity

* sedentary behaviour

* smoking.

Psychiatric factors operate alongside these rather than replacing them.

5. Depression Is Strongly Associated With CAD

Depression is associated with an almost twofold increased risk of developing CAD.

Among patients who already have CAD, depression is associated with approximately double the risk of adverse coronary outcomes, including MI, revascularisation and death.

The graph on page 3 of the chapter strikingly demonstrates progressively poorer five-year cardiac survival after MI with increasing depression severity.

6. Depression May Affect the Heart Through Behaviour

Potential pathways include:

DEPRESSION → SMOKING

DEPRESSION → PHYSICAL INACTIVITY

DEPRESSION → SOCIAL ISOLATION

DEPRESSION → POOR ADHERENCE

These behaviours independently influence cardiovascular risk.

7. Biological Pathways May Also Contribute

Proposed mechanisms include:

* HPA-axis dysregulation

* elevated cortisol

* altered autonomic activity

* endothelial effects

* platelet activation

* increased thrombotic activity.

The relationship is therefore not explained purely by lifestyle.

8. Anxiety Is Common in CAD

Anxiety may affect prognosis independently of depression.

Potential mechanisms again include:

* smoking

* inactivity

* autonomic activation

* reduced adherence

* physiological stress responses.

9. PTSD and Cardiovascular Disease Can Also Interact

PTSD has been associated with:

* CAD

* heart failure

* peripheral vascular disease

* cerebrovascular disease.

Cardiac disease itself can also become the traumatic event.

10. Cardiac Illness Can Cause PTSD

A myocardial infarction can be experienced as:

A LIFE-THREATENING EVENT ARISING FROM WITHIN THE BODY

The patient may subsequently become hypervigilant to:

* heart rate

* chest sensations

* breathlessness

* palpitations

* bodily changes.

Cardiac interventions and ICD shocks can also become traumatic experiences.

11. Acute Mental Stress Produces Cardiovascular Changes

Acute stress can transiently increase:

HEART RATE

and

BLOOD PRESSURE

It can also affect endothelial function and coronary blood flow.

12. Anger Can Have Cardiovascular Effects

Fear, excitement and particularly acute anger can alter coronary blood flow in susceptible people.

In patients with existing atherosclerosis, mental stress can contribute to myocardial ischaemia.

13. Chronic Stress Matters Too

Chronic psychosocial stress has been associated with cardiovascular outcomes.

Relevant factors include:

* job strain

* difficult relationships

* loneliness

* social isolation

* unemployment

* involuntary job loss

* caregiving stress.

Part of this relationship operates through changes in health behaviour.

14. Social Support Is Cardiovascularly Relevant

Low social support has been associated with increased mortality in CAD even after adjustment for some health behaviours.

This reinforces the biopsychosocial nature of cardiovascular medicine.

15. Be Cautious With “Personality Causes Heart Disease”

Historical interest focused heavily on the Type A personality:

* competitiveness

* impatience

* aggression

* time urgency

* anger.

Evidence for a simple Type A → CAD relationship has been inconsistent.

16. Severe Mental Illness Carries Major Cardiovascular Risk

People with schizophrenia, schizoaffective disorder and bipolar disorder have substantially reduced life expectancy.

The chapter reports an average reduction of approximately:

10–17.5 YEARS

CAD is a major contributor.

17. Cardiovascular Risk in Severe Mental Illness Is Multifactorial

Think:

ILLNESS

MEDICATION

SMOKING

INACTIVITY

DIET

SUBSTANCE USE

METABOLIC DISEASE

HEALTHCARE ACCESS

18. Antipsychotics Can Contribute to Metabolic Risk

Some atypical antipsychotics can contribute to:

* weight gain

* insulin resistance

* hyperglycaemia

* dyslipidaemia

* hypertension

* metabolic syndrome.

The chapter particularly identifies clozapine and olanzapine as having high cardiometabolic risk.

19. Smoking Is Particularly Important in Severe Mental Illness

Smoking contributes to:

* endothelial damage

* inflammation

* CAD

* premature mortality.

Smoking cessation also affects the metabolism of some psychotropic medications, so medication levels may change after cessation.

20. Do Not Allow Diagnostic Overshadowing

A psychiatric diagnosis must never become an explanation for every physical symptom.

Someone with schizophrenia can still have an MI.

Someone with panic disorder can still have a pulmonary embolus.

Someone with functional symptoms can still have an arrhythmia.

21. Heart Failure Is a Progressive Syndrome

Typical symptoms include:

* breathlessness

* reduced exercise tolerance

* peripheral oedema.

The chapter describes an approximately:

50% FIVE-YEAR MORTALITY

for heart failure.

22. Heart Failure Can Resemble Psychiatric Illness

Dyspnoea can resemble anxiety or panic.

Orthopnoea can disrupt sleep.

Fatigue can resemble depression.

Therefore somatic symptoms alone may not distinguish the conditions.

23. Look for Cognitive Features of Depression

Features such as:

* hopelessness

* reduced self-esteem

* suicidal ideation

may help distinguish depressive illness from the physical manifestations of heart failure.

24. Depression Is Common and Important in Heart Failure

Depression is associated with:

* poorer self-care

* increased morbidity

* increased mortality.

However, treating depression does not necessarily translate into improved cardiac survival.

25. Cardiac Transplantation Is Psychologically Complex

The patient moves through:

EVALUATION → WAITING → SURGERY → RECOVERY → LONG-TERM ADAPTATION

Possible psychological responses include:

* anxiety

* depression

* elation

* grief

* PTSD

* sleep disturbance

* cognitive difficulties.

26. Transplant Psychiatry Requires Attention to Drug Interactions

Immunosuppressants can themselves cause psychiatric symptoms.

Psychotropics can also alter immunosuppressant concentrations.

Therefore always ask:

“WHAT INTERACTS WITH WHAT?”

27. TCAs Are Generally Avoided After Heart Transplantation

A major reason is their effect on:

CARDIAC CONDUCTION

This principle extends to many patients with significant cardiac conduction disease.

28. Ventricular Assist Devices Create Unique Psychiatric Issues

LVADs may be used as:

* bridge to transplantation

* bridge to recovery

* destination therapy.

Psychiatric assessment includes:

* understanding

* capacity

* cognition

* adherence

* substance use

* social support

* home environment

* ability to manage the device.

29. LVADs Also Create Unique Suicide-Risk Considerations

Because interruption of device function can be lethal, suicide assessment requires specific knowledge of the technology.

Clinicians must also distinguish:

SUICIDALITY

from

A CAPACITOUS DECISION TO WITHDRAW LIFE-SUSTAINING TREATMENT.

30. Takotsubo Syndrome Demonstrates the Mind–Heart Interface Dramatically

Takotsubo syndrome is also called:

STRESS CARDIOMYOPATHY

or

BROKEN HEART SYNDROME

It produces transient ventricular dysfunction and can resemble acute coronary syndrome.

31. Catecholamines Appear Central to Takotsubo Syndrome

Significant:

EMOTIONAL STRESS

or

PHYSICAL STRESS

may precede the syndrome.

The proposed mechanism prominently involves catecholamine-mediated myocardial stunning.

32. Clozapine Has Specific Cardiac Risks

Important complications include:

* myocarditis

* cardiomyopathy

* subclinical cardiotoxicity.

Concerning symptoms include:

DYSPNOEA • TACHYCARDIA • PALPITATIONS • FEVER • CHEST PAIN • FATIGUE

33. Persistent Tachycardia After Starting Clozapine Deserves Attention

Tachycardia can be common with clozapine, but when accompanied by systemic or cardiac symptoms clinicians should consider myocarditis rather than automatically attributing it to a benign medication effect.

34. Infective Endocarditis Demonstrates the Need for Integrated Addiction Care

Injection drug use can cause infective endocarditis.

Optimal treatment requires:

CARDIOLOGY + CARDIAC SURGERY + ADDICTION/PSYCHIATRY

Treating the valve infection without treating the substance-use disorder leaves a major driver of recurrence unaddressed.

35. Evidence-Based Opioid-Use-Disorder Treatment Matters

For opioid-use disorder, medications discussed include:

* buprenorphine

* methadone

* naltrexone.

The chapter emphasises addiction treatment as a core part of managing injection-related endocarditis.

36. Psychiatry Needs Basic ECG Literacy

A systematic ECG assessment considers:

RATE → RHYTHM → INTERVALS → AXIS

Clinical context comes first.

37. Know What the Waves Represent

P wave = atrial depolarisation

QRS = ventricular depolarisation

T wave = ventricular repolarisation

This becomes particularly important when understanding psychotropic cardiac effects.

38. Bradycardia Is <60 bpm

Potential causes include:

* athletic conditioning

* medications

* hypothyroidism

* ischaemia

* conduction disease

* electrolyte abnormalities

* increased vagal tone.

Lithium can contribute to sinus-node dysfunction and bradycardia.

39. Tachycardia Is >100 bpm

Psychotropics with anticholinergic effects can cause sinus tachycardia.

These include:

* TCAs

* many antipsychotics

* MAOIs

* anticholinergic medications.

Clozapine commonly causes tachycardia.

40. Rhythm Can Be Classified Simply

Ask two questions:

Is the QRS narrow or wide?

and:

Is the rhythm regular or irregular?

This rapidly narrows the differential diagnosis.

41. Atrial Fibrillation Is Irregularly Irregular

AF involves disorganised atrial electrical activity.

Therefore:

NO ORGANISED ATRIAL CONTRACTION

IRREGULARLY IRREGULAR VENTRICULAR RESPONSE

Major consequences include stroke and heart failure.

42. Psychological Distress and AF Can Interact

AF is associated with:

* depression

* anxiety

* psychological distress

* reduced quality of life.

Negative emotional states have also been associated with increased likelihood of AF episodes.

43. QT Is About Ventricular Electrical Recovery

The QT interval encompasses:

VENTRICULAR DEPOLARISATION + REPOLARISATION

Because QT varies with heart rate, clinicians use:

QTc

the corrected QT interval.

44. QTc Prolongation Matters Because of Torsades de Pointes

Torsades de pointes is a potentially lethal:

POLYMORPHIC VENTRICULAR TACHYCARDIA

QT prolongation is a marker of increased risk, but QTc alone does not perfectly predict who will develop torsades.

45. Think About the Whole QT Risk Profile

Important risk factors include:

* older age

* female sex

* congenital long-QT syndrome

* structural cardiac disease

* bradycardia

* hypokalaemia

* hypomagnesaemia

* hypocalcaemia

* renal impairment

* hepatic impairment

* acute illness

* multiple QT-prolonging drugs

* pharmacokinetic interactions.

The medication is only one component.

46. Psychotropic Polypharmacy Can Increase Risk

Always consider whether the patient is simultaneously receiving:

* antipsychotics

* antidepressants

* antiarrhythmics

* antibiotics

* antifungals

* antiemetics

* methadone

* other QT-prolonging agents.

Risk can accumulate.

47. Antipsychotics Differ in QT Effects

The chapter identifies aripiprazole and lurasidone as having particularly low QT-prolongation liability.

Greater concern is described with agents including:

* thioridazine

* ziprasidone

* iloperidone.

But individual patient risk factors remain crucial.

48. Citalopram Has Dose-Related QTc Effects

Citalopram produces greater QT prolongation than most other SSRIs.

However, QT effects should be weighed against psychiatric benefit rather than prompting automatic discontinuation or dose reduction.

49. Sertraline Has Been Extensively Studied in Cardiac Patients

Among antidepressants, sertraline has substantial evidence in cardiac populations and is commonly considered a useful first-line SSRI when depression coexists with cardiac disease.

50. SSRIs Can Affect Bleeding

SSRIs reduce platelet serotonin storage and can increase bleeding risk.

Be particularly alert when combined with:

ANTIPLATELETS

or

ANTICOAGULANTS

or

NSAIDs

51. TCAs Affect Cardiac Conduction

TCAs can cause:

* QRS widening

* conduction delay

* heart block

* tachycardia

* orthostatic hypotension

* ventricular arrhythmias in overdose.

This explains why TCAs require particular caution in cardiac disease.

52. Lithium Has Several Potential Cardiac Effects

Lithium has been associated with:

* bradycardia

* sinus-node dysfunction

* sinus block

* sinus arrest

* AV conduction abnormalities.

Risk assessment must also consider lithium-induced hypothyroidism and interacting medications.

53. Methadone Is Important in QT Assessment

Methadone has a clear association with:

QTc PROLONGATION

and

TORSADES DE POINTES

The chapter describes buprenorphine as a safer alternative from a QT perspective.

54. But Cardiac Monitoring Should Not Become a Barrier to Addiction Treatment

The clinical task is balancing:

CARDIAC SAFETY

with

ACCESS TO LIFE-SAVING OPIOID-USE-DISORDER TREATMENT

rather than allowing monitoring requirements to inadvertently prevent treatment.

55. Cardiac Devices Matter to Psychiatry

Important devices include:

* permanent pacemakers

* implanted cardioverter-defibrillators

* cardiac resynchronisation therapy.

Psychiatrists treating complex cardiac patients should understand their basic functions.

56. ICD Shocks Can Be Psychologically Traumatic

Repeated shocks may produce:

* anticipatory anxiety

* hypervigilance

* avoidance

* PTSD symptoms.

The device saves life but can itself become associated with fear.

57. Do Not Automatically Blame Patients for Device Problems

Lead migration was historically labelled “twiddler’s syndrome”, implying patient manipulation.

The chapter highlights evidence questioning this assumption.

This is an important example of how psychiatric labels can contribute to diagnostic stigma.

58. Cardiac Disease Can Masquerade as Psychiatric Illness

Always remember:

HEART → APPARENT PSYCHIATRIC SYMPTOMS

Examples include:

* arrhythmia → panic-like symptoms

* syncope → seizure-like events

* pulmonary embolism → anxiety/panic

* cardiac disease → fatigue/depression-like symptoms.

59. Syncope Can Resemble Seizures

Cerebral hypoxia during syncope may produce:

* jerking

* convulsive movements

* transient loss of consciousness.

Torsades can also present with seizure-like activity.

60. Pulmonary Embolism Can Resemble Panic

Both may cause:

* dyspnoea

* chest pain

* palpitations

* anxiety

* light-headedness

* fainting.

New-onset “panic” with physiological abnormalities or thromboembolic risk factors requires medical consideration.

61. Diagnostic Overshadowing Can Be Dangerous

A known psychiatric diagnosis can lead clinicians to interpret new symptoms psychologically.

The corrective question is:

“WHAT WOULD I THINK THIS WAS IF THE PATIENT HAD NO PSYCHIATRIC HISTORY?”

62. Psychiatry Can Also Masquerade as Cardiac Disease

Panic disorder, anxiety, PTSD, depression and somatic symptom disorder may present with:

* chest pain

* breathlessness

* palpitations

* dizziness

* autonomic symptoms.

Appropriate medical exclusion and psychiatric recognition are both important.

63. Depression Treatment in Cardiac Disease Is Multimodal

Options include:

* SSRIs

* CBT

* interpersonal therapy

* collaborative care

* exercise

* cardiac rehabilitation

* stress-management interventions.

Treatment should address both psychological suffering and cardiovascular rehabilitation.

64. Anxiety Is Common After Cardiac Events

After acute coronary syndromes and cardiac surgery, anxiety may reflect:

* fear of recurrence

* fear of death

* heightened attention to bodily sensations

* loss of confidence in the body

* uncertainty about exertion.

Psychological interventions can be helpful.

65. Delirium Is Common in Severely Ill Cardiac Patients

Potential contributors include:

* hypoxia

* hyponatraemia

* hepatic failure

* renal dysfunction

* cerebral hypoperfusion

* infection

* sedatives

* opioids

* surgery.

Treatment begins with identifying and correcting the underlying cause.

66. Cardiovascular Drugs Can Cause Psychiatric Symptoms

Always review the cardiac medication list when new psychiatric symptoms develop.

Examples discussed include:

DIGOXIN → hallucinations/delirium

ANTIARRHYTHMICS → delirium, hallucinations or mood disturbance

AMIODARONE → hypothyroidism → cognitive slowing/depressed mood

67. Amiodarone Is Particularly Important

Amiodarone can cause substantial hypothyroidism.

Therefore:

AMIODARONE → HYPOTHYROIDISM → FATIGUE + COGNITIVE DULLING + LOW MOOD

may be mistaken for primary depression.

68. Drug Interactions Can Be Cardiovascularly Dangerous

Amiodarone inhibits several cytochrome P450 enzymes and may increase concentrations of psychotropic medications.

Therefore the interaction itself may increase toxicity and arrhythmia risk.

69. The Central Cardiopsychiatry Assessment

When Holmes encounters psychiatric symptoms in someone with cardiovascular disease, he asks:

1. Is there an acute cardiac problem?

2. Could the cardiac disease explain the psychiatric symptoms?

3. Could psychiatric illness be affecting cardiac risk or treatment?

4. Could a psychotropic medication be affecting the heart?

5. Could a cardiac medication be affecting the mind?

6. Are there important drug interactions?

7. What does the ECG show?

8. Are electrolytes or organ dysfunction increasing risk?

9. Are behavioural factors modifiable?

10. Is diagnostic overshadowing occurring?

70. The Core Principle

The relationship is not:

HEART OR MIND

It is:

HEART ↔ BRAIN ↔ EMOTION ↔ BEHAVIOUR ↔ TREATMENT

The best cardiopsychiatric care protects both sides of that system.

Medlock Holmes enters The Hospital of Two Wings.

For generations, one wing has been labelled BODY and the other MIND. Patients are routinely carried from one to the other, as though every symptom must belong exclusively to one side.

Holmes immediately notices the flaw.

A bridge connects them.

Consultation-liaison psychiatry operates on this bridge: the part of psychiatry concerned with psychiatric problems arising within medical settings and with the complex, bidirectional relationships between physical illness and mental health. The older term psychosomatic medicine literally reflects the relationship between psyche and soma - mind and body - but historically became burdened by the misleading implication that symptoms were somehow imaginary or “all in the head”. The field increasingly adopted the name consultation-liaison psychiatry to better describe its clinical work.

The history of the specialty becomes a detective story in its own right. Holmes follows medicine from ancient recognition that emotions influence the body, through hysteria and conversion, psychoanalytic theories, physiological models of stress, psychoneuroimmunology and finally the modern biopsychosocial model.

The crucial insight is that causation rarely travels in only one direction:

PHYSICAL ILLNESS ↔ BRAIN ↔ PSYCHOLOGICAL RESPONSE ↔ BEHAVIOUR ↔ SOCIAL ENVIRONMENT

Modern C-L psychiatry therefore addresses an enormous range of problems: delirium and dementia caused by medical disease; depression and anxiety occurring alongside physical illness; psychiatric effects of medications such as corticosteroids; somatic symptom disorders; substance withdrawal; psychiatric complications of psychotropic treatment; adjustment to cancer, transplantation, disability or terminal illness; suicidality; treatment adherence; and assessment of decision-making capacity.

Holmes also discovers why this matters beyond psychological wellbeing. Psychiatric morbidity is exceptionally common among medically ill patients and can affect treatment adherence, disability, length of hospitalisation, quality of life and medical outcomes. The chapter reports psychiatric morbidity in roughly 20–65% of patients with medical conditions, depending on the illness, with delirium occurring in approximately 20% of hospital inpatients.

Assessment therefore demands more than a conventional psychiatric interview. Holmes must examine the medical record, medications, laboratory investigations, neurological findings, cognition, collateral information, the reason the treating team requested help and - crucially - the patient’s own experience of illness.

Treatment is similarly integrated. Psychotropic prescribing must account for organ function, drug interactions and medical vulnerability, while psychotherapy may address fear, disability, pain, changing roles, adherence, loss, dying and adaptation.

By the end, Holmes removes the old signs from the hospital.

There is no separate Mind Hospital and Body Hospital.

There is only:

THE PATIENT

Key Takeaways

1. Consultation-Liaison Psychiatry Sits at the Medicine–Psychiatry Interface

C-L psychiatry specialises in psychiatric assessment and treatment within the context of physical illness.

Its central question is:

“How are the medical and psychiatric problems interacting?”

2. “Psychosomatic” Does Not Mean Imaginary

Historically, psychosomatic became associated with the dismissive idea that unexplained symptoms were “all in your head”.

That is misleading.

The original concept concerns relationships between:

PSYCHE ↔ SOMA

or:

MIND ↔ BODY

3. Modern Medicine Rejects a Simple Mind–Body Split

Physical illness can cause psychiatric symptoms.

Psychiatric illness can influence physical health.

Medical treatment can produce psychiatric complications.

Psychological responses can influence symptoms, behaviour and treatment.

Social circumstances affect both.

Therefore:

BIOLOGY ↔ PSYCHOLOGY ↔ SOCIAL CONTEXT

4. The History of Psychosomatic Medicine Is Important

Ancient physicians already recognised that emotional states could produce bodily responses.

The chapter describes Hippocrates observing associations such as:

FEAR → SWEATING

SHAME → PALPITATIONS

The modern terminology changed dramatically, but recognition of mind–body interaction is ancient.

5. Historical Explanations Were Often Wrong

Medicine previously attributed unexplained symptoms to theories including:

* hysteria

* uterine disease

* “reflex neurosis”

* nervous fluid

* spinal irritation

* neurasthenia.

Some patients underwent unnecessary and harmful treatments because erroneous theories were treated as established fact.

An important clinical lesson follows:

UNEXPLAINED DOES NOT MEAN UNREAL.

And:

CURRENTLY UNEXPLAINED DOES NOT MEAN MEDICALLY EXCLUDED FOREVER.

6. Symptom Presentation Is Influenced by Culture

The ways people understand and express illness change across historical periods and cultures.

Historical presentations dominated by paralysis and dramatic neurological symptoms later shifted towards presentations such as:

* fatigue

* chronic pain

* other bodily symptoms.

Illness occurs biologically, but its experience and expression are also socially shaped.

7. Freud Helped Reconnect Psyche and Soma

Psychodynamic theories emphasised how psychological conflict could be expressed through physical symptoms.

Some historical explanations were subsequently unsupported, but they helped medicine reconsider the possibility that emotion, meaning and bodily experience interact.

8. Early Psychosomatic Theories Often Became Too Specific

Some theorists attempted to link:

SPECIFIC PERSONALITY → SPECIFIC CONFLICT → SPECIFIC DISEASE

For example, particular personality styles were historically proposed to cause particular gastrointestinal or cardiovascular diseases.

The evidence did not support such simple one-to-one relationships.

9. Stress Became a More General Biological Model

Later theories examined how stress activates physiological systems rather than assuming one specific psychological conflict causes one specific disease.

Important systems include:

* autonomic nervous system

* hypothalamic-pituitary-adrenal axis

* endocrine pathways

* cardiovascular responses

* immune pathways.

10. The Biopsychosocial Model Integrates These Systems

George Engel’s biopsychosocial framework conceptualised illness through interacting:

BIOLOGICAL FACTORS

disease, genetics, physiology, medications

PSYCHOLOGICAL FACTORS

emotion, cognition, behaviour, coping

SOCIAL FACTORS

relationships, culture, socioeconomic circumstances, environment.

The model does not replace biology.

It places biology within a larger system.

11. Psychiatric Morbidity Is Common in Medical Patients

The chapter reports psychiatric morbidity in medically ill populations ranging approximately from:

20–65%

depending upon the illness and population.

General-hospital patients have particularly high psychiatric morbidity.

12. Delirium Is Particularly Important

Approximately:

20% OF HOSPITAL INPATIENTS

may experience delirium.

It is associated with worse functional and postoperative outcomes.

Therefore altered behaviour in hospital must never automatically be assumed to represent a primary psychiatric illness.

13. Always Ask Whether Medicine Is Causing Psychiatry

A useful C-L question is:

“Could the medical condition be producing the psychiatric presentation?”

Examples include:

Delirium ← medical illness

Dementia ← neurological disease

Mood/behavioural disturbance ← neurological or endocrine disease

14. Then Ask Whether Medical Treatment Is Causing Psychiatry

Medications themselves can produce psychiatric syndromes.

A classic example from the chapter is:

CORTICOSTEROIDS → MANIA

Other treatments may contribute to:

* delirium

* mood disturbance

* cognitive impairment

* anxiety

* psychosis.

15. Psychiatric Illness Can Also Complicate Medical Treatment

The direction can reverse:

PSYCHIATRIC ILLNESS → MEDICAL CONSEQUENCES

For example, psychiatric illness may influence:

* treatment adherence

* self-care

* substance use

* nutrition

* rehabilitation

* engagement with clinicians.

16. Sometimes Both Conditions Simply Coexist

Not every association is causal.

A patient can simultaneously have:

SCHIZOPHRENIA + RENAL FAILURE

or:

DEPRESSION + CANCER

without one necessarily causing the other.

Good formulation distinguishes causation, reaction, complication and coincidence.

17. C-L Psychiatry Therefore Solves Several Different Mysteries

Ask whether the presentation represents:

MEDICAL → PSYCHIATRIC

TREATMENT → PSYCHIATRIC

PSYCHIATRIC → MEDICAL

PSYCHOLOGICAL FACTORS ↔ PHYSICAL SYMPTOMS

or:

MEDICAL + PSYCHIATRIC CO-OCCURRENCE

This is one of the most useful frameworks for understanding the specialty.

18. Common Reasons for Psychiatric Consultation Include

* suicidal behaviour

* delirium

* psychosis

* depression

* anxiety

* disturbed behaviour

* treatment refusal

* conflict with staff

* psychiatric medication complications

* disposition difficulties

* capacity questions

* preparation for major procedures or transplantation.

19. The Referral Question Matters

Before seeing the patient, ask:

“Why has psychiatry actually been called?”

The written referral may say:

“Depression?”

while the real issue is:

“The patient refuses dialysis and the team doesn’t know whether they have capacity.”

Clarifying the question fundamentally changes the assessment.

20. Speak to the Treating Team

The psychiatrist should understand:

* what has happened

* what concerns the team

* what decisions need to be made

* what behaviour has changed

* what treatments have been attempted

* what the team expects from psychiatry.

Sometimes the team’s emotional response to the patient is itself clinically informative.

21. Collateral Information Is Often Essential

Information may be required from:

* family

* GP

* medical specialists

* nurses

* previous mental-health teams

* medical records.

This is particularly important when cognition, consciousness or reliability is impaired.

22. Medical Records Matter

C-L psychiatrists need to understand:

DIAGNOSIS

MEDICATIONS

INVESTIGATIONS

OPERATIONS

PHYSIOLOGY

PROGNOSIS

CURRENT TREATMENT

Psychiatry cannot be meaningfully separated from the medical context.

23. Cognition Deserves Particular Attention

Assess:

* consciousness

* attention

* concentration

* memory

* executive function

* language

* praxis

* perception

* judgement

* insight.

When a medically ill patient’s mental state changes acutely:

THINK DELIRIUM.

24. Investigations May Be Psychiatric Investigations Too

Depending on the presentation, evaluation may require:

* blood chemistry

* haematology

* thyroid function

* liver function

* vitamin B12

* folate

* toxicology

* infection testing

* CT

* MRI

* EEG

* lumbar puncture.

A psychiatric presentation may have a biological explanation that requires active investigation.

25. Understand the Patient’s Experience of Illness

Do not merely ask:

“What disease does this patient have?”

Ask:

“What does having this disease mean to this person?”

Illness may threaten:

* independence

* identity

* employment

* relationships

* sexuality

* body image

* future plans

* mortality

* control.

26. Coping Styles Matter

Two people with identical medical diagnoses may respond completely differently.

One may seek information.

Another avoids it.

One becomes dependent.

Another rejects help.

One catastrophises.

Another minimises danger.

Understanding coping improves both psychiatric and medical care.

27. Decision-Making Capacity Is a Core C-L Skill

C-L psychiatrists frequently assess whether someone can make a particular healthcare decision.

Capacity is not simply:

“Does the patient agree with the doctor?”

A person may make a decision clinicians dislike and still possess capacity.

The assessment concerns the person’s ability to make the relevant decision.

28. Suicidality Remains Central

C-L psychiatrists assess and manage suicidal behaviour within medically complex environments.

This may include:

* intentional overdose

* self-injury

* treatment refusal

* severe depression

* terminal illness

* delirium

* chronic pain

* demoralisation.

The medical context changes the formulation but never eliminates the need for careful risk assessment.

29. Psychotropic Prescribing Is Different in Medical Illness

Always consider:

DRUG–DRUG INTERACTIONS

HEPATIC FUNCTION

RENAL FUNCTION

CARDIOVASCULAR RISK

METABOLIC EFFECTS

NEUROLOGICAL VULNERABILITY

THE UNDERLYING DISEASE

The “usual psychiatric dose” is not automatically the appropriate medical-patient dose.

30. Psychotherapy Also Changes in the Medical Setting

Therapy may be:

* shorter

* bedside-based

* supportive

* highly focused

* interrupted by procedures

* directed towards immediate adaptation.

Approaches may include:

supportive psychotherapy

CBT

dynamic approaches

family interventions

group interventions

31. Therapy Often Addresses Loss

Medical illness can produce losses of:

* health

* function

* occupation

* independence

* identity

* relationships

* future expectations.

Psychotherapy may help the patient construct a workable life around these changes.

32. Terminal Illness Introduces Different Questions

Treatment may focus upon:

* meaning

* fear

* death

* dying

* family

* symptom burden

* autonomy

* dignity

* grief.

The goal is not always cure.

Sometimes the goal is helping someone live meaningfully within what cannot be cured.

33. Mental Illness Can Worsen Physical Outcomes

The chapter describes associations between psychiatric morbidity and poorer outcomes in conditions including:

* coronary artery disease

* diabetes

* stroke

* HIV

* cancer

* neurodegenerative disease.

Psychiatric treatment is therefore part of whole-person medical care rather than an optional addition.

34. Social Determinants Belong in the Formulation

Mental illness is associated with increased exposure to:

* homelessness

* poverty

* financial insecurity

* nutritional insecurity

* other adverse social circumstances.

These can worsen both psychiatric and medical outcomes.

35. Primary Care Is a Major Mental-Health Setting

Mental-health conditions are common among people with chronic physical illnesses in primary care but may remain unrecognised or undertreated.

Integration therefore matters.

36. Collaborative Care Is One Response

The Collaborative Care Model brings together:

PRIMARY CARE CLINICIAN

BEHAVIOURAL HEALTH CARE MANAGER

CONSULTING PSYCHIATRIST

to systematically identify and treat mental-health conditions within primary care.

The chapter describes evidence for improved quality of care, clinical outcomes, satisfaction and adherence.

37. Modern Psychosomatic Research Is Broad

It now examines:

* epidemiology

* neurobiology

* inflammation

* psychoneuroimmunology

* chronic pain

* fatigue

* functional neurological symptoms

* treatment outcomes

* adherence

* healthcare utilisation

* integrated-care models

* social determinants.

The field has moved far beyond simplistic ideas that one emotion produces one physical disease.

38. The Central C-L Formulation

When Holmes encounters psychiatric symptoms in a medically ill patient, he asks:

1. What is the medical illness?

2. What is the psychiatric syndrome?

3. Could the medical illness cause it?

4. Could treatment cause it?

5. Is it a psychological reaction to illness?

6. Could psychiatric illness be affecting medical care?

7. Are the two conditions independent?

8. What social factors connect them?

9. What does the illness mean to the patient?

10. What intervention helps the whole system?

The final principle is:

DO NOT CHOOSE BETWEEN MIND AND BODY.

UNDERSTAND THE PERSON IN WHOM BOTH EXIST.

Personality disorder emerges not because someone has a distinctive personality, but when enduring patterns become sufficiently inflexible and maladaptive to repeatedly disrupt the self, relationships and functioning.

Medlock Holmes enters The House of Personality, an extraordinary mansion that has been under construction since childhood.

Its foundations contain inherited temperament. Its rooms have been shaped by development and experience. Its doors determine how readily someone approaches or avoids the world; its windows influence how they interpret other people; and its internal corridors represent the habitual ways in which emotion, identity, relationships and behaviour become connected.

Every house is different.

Difference itself is not disorder.

The mystery begins when Holmes discovers that some houses have become rigid. The same doors open regardless of circumstance. The same corridors are travelled despite repeatedly leading to conflict. Strategies that may once have been adaptive become increasingly difficult to modify.

This chapter takes Holmes beneath diagnostic labels to explore the architecture of personality itself. Personality is presented as a dynamic biopsychosocial system emerging from interactions between temperament, character, learning, development, environment and self-awareness.

Holmes encounters two competing maps of personality disorder. The traditional DSM model divides disorders into three familiar clusters: Cluster A, characterised broadly by odd or eccentric patterns; Cluster B, by dramatic, emotional or impulsive patterns; and Cluster C, by anxious or fearful patterns. Yet the boundaries overlap considerably.

A newer dimensional perspective asks a different question. Rather than simply asking “Which personality disorder does this person have?”, clinicians can ask:

“How impaired is personality functioning, and what traits characterise that impairment?”

This becomes particularly important in ICD-11, where personality disorder is primarily classified by severity - mild, moderate or severe - followed by trait qualifiers.

The chapter also challenges therapeutic pessimism. Personality is relatively enduring, but it is not necessarily immutable. Psychotherapy, relationships, learning and increasing self-awareness can alter how people regulate emotion, pursue goals, understand themselves and relate to others.

Holmes therefore leaves the mansion with a different question from the one with which he entered.

Not:

“What kind of difficult person is this?”

But:

“What enduring pattern is operating here, how did it develop, what function does it serve, and where might greater flexibility become possible?”

Key Takeaways

1. Personality Is Not the Same as Personality Disorder

Personality describes relatively enduring patterns in how someone:

* experiences themselves

* experiences other people

* regulates emotions

* behaves

* pursues goals

* adapts to the environment.

Having unusual or extreme traits does not automatically indicate pathology.

The chapter specifically emphasises that even extreme temperament variants need not produce personality disorder.

2. Think in Terms of Adaptation

A useful overarching model is:

PERSONALITY = TEMPERAMENT × CHARACTER × DEVELOPMENT × EXPERIENCE × SELF-AWARENESS

Personality is not merely something a person has.

It is part of the system through which they continually adapt.

3. Personality Disorder Involves Enduring Maladaptation

The important features are:

PERSISTENT

PERVASIVE

INFLEXIBLE

MALADAPTIVE

and associated with significant dysfunction or impairment.

The problem is therefore not simply possessing a trait, but being unable to adapt that trait sufficiently to changing circumstances.

4. Temperament and Character Are Different

One of the chapter’s major conceptual distinctions is between temperament and character.

Temperament refers more closely to biologically influenced emotional and behavioural tendencies.

Character involves higher-order development of goals, values, identity and self-regulation.

The chapter’s psychobiological model therefore argues that temperament influences how someone reacts, while character helps determine how those reactions are regulated and integrated.

5. Four Temperament Dimensions

The Temperament and Character Inventory describes:

* Novelty Seeking

* Harm Avoidance

* Reward Dependence

* Persistence

Different combinations create different behavioural styles.

None is inherently pathological.

6. Three Character Dimensions

The model adds:

* Self-Directedness

* Cooperativeness

* Self-Transcendence

Low self-directedness and cooperativeness are particularly associated with personality-disorder symptoms across diagnostic clusters.

A useful conceptual distinction is therefore:

TRAIT EXTREMITY ≠ PERSONALITY DISORDER

The crucial issue is whether the person’s overall personality system can regulate those traits adaptively.

7. Personality Emerges From Biology and Experience

Personality development reflects interactions among:

GENES ↔ BRAIN ↔ LEARNING ↔ FAMILY ↔ CULTURE ↔ EXPERIENCE ↔ SELF-AWARENESS

The chapter describes substantial genetic influences on personality while equally emphasising environmental, developmental and epigenetic processes.

Biology provides predispositions - not destiny.

8. Personality Development Is Nonlinear

The same childhood temperament does not inevitably lead to the same adult personality.

This is multifinality:

SIMILAR BEGINNING → DIFFERENT OUTCOMES

Conversely, different developmental pathways can eventually produce similar clinical patterns.

Personality therefore cannot be reconstructed from one simplistic childhood explanation.

9. Personality Patterns Can Become Self-Reinforcing

A person’s habitual responses influence their environment.

The environment then responds to them.

That response can reinforce the original behaviour:

TRAIT → BEHAVIOUR → ENVIRONMENTAL RESPONSE → LEARNING → STRONGER TRAIT EXPRESSION

Over decades, these loops can become remarkably stable.

This helps explain why personality disorders may feel both persistent and resistant to change.

10. The Traditional DSM System Uses Three Clusters

Cluster A - Odd or Eccentric

Includes:

Paranoid • Schizoid • Schizotypal

Cluster B - Dramatic, Emotional or Erratic

Includes:

Antisocial • Borderline • Histrionic • Narcissistic

Cluster C - Anxious or Fearful

Includes:

Avoidant • Dependent • Obsessive-Compulsive

But the chapter stresses that these clusters and individual diagnoses overlap substantially.

11. Categorical Diagnosis Has Limitations

Traditional diagnosis asks:

DISORDER PRESENT OR ABSENT?

This is clinically convenient.

But personality traits usually exist on continua.

Drawing a categorical line through a continuous characteristic inevitably introduces some arbitrariness.

It also struggles with patients who have significant features of several disorders without fitting neatly into one prototype.

12. Dimensional Models Ask a Different Question

Instead of:

“Which box?”

they ask:

“How severe is the dysfunction, and what traits describe it?”

This may better reflect the reality that personality characteristics exist along dimensions.

13. ICD-11 Makes Severity Central

ICD-11 represents an important conceptual shift.

First assess personality-disorder severity:

MILD → MODERATE → SEVERE

Then describe prominent traits.

The emphasis moves away from accumulating categorical labels and towards understanding the degree and nature of personality dysfunction.

14. ICD-11 Trait Domains

The dimensional formulation can include:

* Negative Affectivity

* Detachment

* Dissociality

* Disinhibition

* Anankastia

with a borderline pattern qualifier also available.

These describe how personality dysfunction manifests rather than assuming every patient belongs to a discrete personality “type”.

15. Assess Self and Interpersonal Functioning

A particularly useful clinical framework is to examine:

SELF

Identity

Who am I?

Self-direction

Can I establish and pursue coherent goals?

INTERPERSONAL

Empathy

Can I understand another person’s experience?

Intimacy

Can I develop reciprocal, enduring relationships?

Personality pathology often becomes most visible in these domains.

16. Ego-Syntonicity Can Complicate Assessment

Many personality traits are experienced as:

“THIS IS JUST WHO I AM.”

rather than:

“SOMETHING IS HAPPENING TO ME.”

This differs from many episodic psychiatric disorders.

The patient may therefore present because of:

* depression

* anxiety

* relationship breakdown

* substance misuse

* occupational difficulties

* self-harm

* interpersonal crisis

rather than complaining directly about their personality.

17. Defence Mechanisms Can Become Habitual

The chapter revisits psychodynamic formulations in which defensive strategies become entrenched components of personality.

Examples discussed include:

Projection → paranoid patterns

Acting out → antisocial patterns

Fantasy → schizoid patterns

The broader lesson is more important than memorising pairings:

A DEFENCE THAT PROTECTS IN ONE CONTEXT MAY BECOME MALADAPTIVE WHEN USED EVERYWHERE.

18. Assessment Requires Longitudinal Thinking

Do not diagnose personality disorder from behaviour during a single crisis.

Ask:

Has this pattern existed for years?

Does it occur across settings?

What happens in relationships?

What was functioning like before the current illness?

How does the patient understand themselves?

What do collateral sources describe?

Personality is fundamentally longitudinal.

19. State Can Be Mistaken for Trait

Depression may make someone appear chronically pessimistic.

Mania may produce impulsivity or grandiosity.

PTSD may produce mistrust.

Psychosis may produce suspiciousness.

Substances may produce instability.

Autism may affect social interaction.

Therefore:

STATE ≠ TRAIT

until longitudinal assessment demonstrates otherwise.

20. Comorbidity Is Common

Personality disorders frequently coexist with:

* mood disorders

* anxiety disorders

* substance-use disorders

* eating disorders

* trauma-related disorders

* other personality disorders.

Multiple categorical personality diagnoses may partly reflect weaknesses in the boundaries between existing categories.

21. Assessment Tools Can Help - But Do Not Replace Formulation

The chapter discusses structured interviews and personality measures including:

* structured diagnostic interviews

* personality inventories

* dimensional trait measures

* Temperament and Character Inventory.

These can organise information.

They do not replace clinical history, longitudinal observation and contextual formulation.

22. Treatment Requires More Than Symptom Suppression

Medication may help particular co-occurring symptoms or disorders.

But there is no medication that simply removes a personality disorder.

Treatment aims at deeper capacities such as:

EMOTIONAL REGULATION

SELF-UNDERSTANDING

FLEXIBILITY

RELATIONSHIP FUNCTION

GOAL-DIRECTED BEHAVIOUR

SELF-REGULATION

23. Psychotherapy Is Central

Different disorders and presentations may benefit from different structured approaches.

But across therapies, the deeper objective is often similar:

RIGID PATTERN → AWARENESS → ALTERNATIVE RESPONSE → PRACTICE → GREATER FLEXIBILITY

The therapeutic relationship itself may also reveal the patient’s characteristic interpersonal patterns.

24. Personality Is Enduring - Not Frozen

This distinction is fundamental.

Personality traits can be stable enough to recognise across decades while still remaining capable of modification through:

* maturation

* relationships

* psychotherapy

* learning

* environmental change

* deliberate self-reflection.

The chapter’s developmental diagrams reinforce this idea: temperament influences possible pathways, but does not dictate a single inevitable character outcome.

25. Holmes’ Personality Formulation

Rather than stopping at a diagnostic label, ask:

What are the dominant traits?

How severe is the dysfunction?

How does the person experience themselves?

How do they relate to others?

What happens when they are stressed?

Which patterns repeatedly create problems?

How did those patterns develop?

What function have they served?

Where is there capacity for flexibility and change?

The central principle becomes:

“Personality disorder is not simply about who someone is - it is about where enduring ways of being have become rigid enough to prevent adaptation.”

Medlock Holmes enters The House of Adaptation, where people arrive carrying the weight of events that have changed their lives: relationship breakdown, financial hardship, illness, unemployment, conflict, relocation, bereavement and unexpected transitions.

But Holmes immediately encounters psychiatry’s central difficulty with adjustment disorder:

“When does distress become disorder?”

Adjustment disorder is defined by the development of significant emotional or behavioural symptoms in response to an identifiable stressor. Unlike PTSD, the stressor does not have to involve threatened death, serious injury or sexual violence. It may instead be an event encountered routinely in human life - divorce, losing a job, financial problems, illness or major life transition.

In DSM-5-TR, symptoms develop within 3 months of the stressor and cause either distress that is disproportionate to the stressor, taking cultural and contextual factors into account, or significant impairment in functioning. Once the stressor or its consequences have ended, symptoms should not persist beyond 6 months.

Yet this apparently simple diagnosis contains a profound clinical dilemma. There is no precise laboratory test or symptom threshold separating adjustment disorder from an understandable response to adversity. Holmes must understand the person, the stressor, its meaning, their culture, previous vulnerabilities, available supports and capacity for adaptation.

The disorder may present with depression, anxiety, conduct disturbance, or mixtures of these. ICD-11 approaches the diagnosis somewhat differently, emphasising preoccupation with the stressor and failure to adapt, and requiring symptoms to emerge within one month.

Adjustment disorder is often regarded as relatively mild and self-limiting, but that assumption can be dangerous. Suicidal ideation and self-harm can occur, sometimes relatively early and impulsively, making careful risk assessment essential.

Treatment therefore focuses less on simply suppressing symptoms and more on restoring the process of adaptation: understanding the stressor, mobilising social support, strengthening coping and problem-solving, reducing avoidable stress, and helping the person regain functioning. Psychotherapy and psychosocial interventions remain central, while medication may sometimes target significant anxiety, insomnia or depressive symptoms.

Holmes eventually discovers that the stressor is only one part of the equation.

Two people can experience the same event and follow entirely different paths.

The real mystery lies in the relationship between:

STRESSOR × MEANING × VULNERABILITY × SUPPORT × RESILIENCE

Adjustment disorder sits precisely at that intersection - between adversity and adaptation, and between ordinary suffering and psychiatric disorder.

Key Takeaways

1. An Identifiable Stressor Is Essential

Adjustment disorder cannot be diagnosed without a recognisable:

STRESSOR → EMOTIONAL / BEHAVIOURAL RESPONSE

Common stressors include relationship, financial, occupational and medical difficulties.

2. The Stressor Does Not Need to Be Traumatic

Unlike PTSD, adjustment disorder can follow ordinary but significant life events.

The key question is not simply how objectively severe the event was, but how the individual responded to it.

3. Timing Matters

Under DSM-5-TR:

STRESSOR → SYMPTOMS WITHIN 3 MONTHS

Once the stressor or its consequences end:

SYMPTOMS SHOULD RESOLVE WITHIN 6 MONTHS

Persistent stressors can therefore sustain the disorder.

4. Distress Alone Is Not Enough

Human beings normally become distressed by difficult events.

Diagnosis requires either:

* disproportionate distress, considering context and culture, or

* significant impairment in social, occupational or other functioning.

This makes the boundary between normality and pathology particularly difficult.

5. DSM-5-TR Recognises Six Subtypes

The table in the chapter identifies:

* with depressed mood

* with anxiety

* with mixed anxiety and depressed mood

* with disturbance of conduct

* with mixed disturbance of emotions and conduct

* unspecified.

6. ICD-11 Conceptualises Adjustment Disorder Differently

ICD-11 particularly emphasises:

PREOCCUPATION WITH THE STRESSOR

and

FAILURE TO ADAPT

Symptoms generally develop within 1 month rather than the DSM’s 3-month window.

7. Differential Diagnosis Is Crucial

Consider:

* normal response to stress

* major depressive disorder

* anxiety disorders

* acute stress disorder

* PTSD

* prolonged grief disorder

* substance-related disorders

* medical causes of psychiatric symptoms

* demoralisation.

A stressor does not automatically make the diagnosis adjustment disorder.

8. Context and Culture Matter

Whether distress is considered disproportionate cannot be judged independently of:

* culture

* values

* developmental stage

* social circumstances

* meaning of the event

* available support.

9. Vulnerability and Resilience Modify the Response

The clinical pathway can be conceptualised as:

STRESSOR × VULNERABILITY × MEANING × SUPPORT → RESPONSE

Previous adversity, coping style and psychiatric vulnerability may increase risk.

Protective factors include emotional regulation, optimism, effective coping, positive self-concept and supportive relationships.

10. Adjustment Disorder Is Not Necessarily “Minor”

Symptoms may include:

* depression

* anxiety

* insomnia

* low self-esteem

* hypervigilance

* impulsivity

* substance use

* behavioural disturbance.

Some people experience substantial functional impairment.

11. Suicide Risk Must Be Taken Seriously

The chapter particularly emphasises the association between adjustment disorder and:

SUICIDAL IDEATION • SELF-HARM • SUICIDE

Some suicidal behaviour may emerge rapidly following the precipitating stressor.

Never equate a “subthreshold” diagnosis with subthreshold risk.

12. Course Is Often Favourable - But Not Always

Many adults recover as adaptation occurs.

However, symptoms may:

RESOLVE

or

PERSIST / EVOLVE INTO ANOTHER DISORDER

including major depression, PTSD or generalised anxiety disorder.

Persistent symptoms and behavioural disturbance are important warning signs.

13. Treatment Targets Adaptation

The aim is not merely symptom reduction.

Treatment seeks to:

* understand the meaning of the stressor

* restore functioning

* strengthen coping

* mobilise support

* improve problem-solving

* reduce modifiable stressors

* strengthen resilience.

14. Psychotherapy Is the Mainstay

Approaches described include:

* supportive psychotherapy

* CBT

* problem-solving therapy

* relaxation

* psychodynamic approaches

* mindfulness

* ACT

* family and couples work

* group interventions

* crisis intervention.

Treatment should match the person’s particular adaptation problem.

15. Medication Has a Secondary Role

Medication may sometimes target prominent:

* anxiety

* insomnia

* depressive symptoms.

However, the pharmacological evidence base remains limited, and psychosocial approaches remain central.

Particular caution is required with benzodiazepines because even relatively short treatment can produce dependence or withdrawal problems.

16. Holmes’ Central Diagnostic Questions

What happened?

What did it mean to this person?

How did they respond?

Has functioning deteriorated?

Is this beyond an expected response?

Is another disorder a better explanation?

Are they safe?

The defining clinical principle is:

“Do not diagnose the stressor. Diagnose the person’s response to it.”

Medlock Holmes enters a vast Neo-Victorian department store where an unusual investigation is underway.

An object has been stolen.

But the person who took it did not need it. The object had little personal importance. They could easily have afforded it. They may not even use it afterwards - sometimes the stolen objects are hidden, hoarded, given away or even secretly returned.

So Holmes asks the question that defines the investigation:

“If they did not need the object, why did they steal it?”

Kleptomania is characterised by a recurrent failure to resist impulses to steal objects that are not needed for personal use or monetary value. Immediately before the theft there is typically increasing tension; during the theft there is pleasure, gratification or relief. Afterwards, however, the person may experience guilt, shame, depression and considerable distress.

The theft is usually not carefully planned. Little attention may be given to the consequences in the moment. The urge itself is often ego-dystonic: the person recognises that the behaviour conflicts with their values and may desperately wish they could stop.

This creates the characteristic cycle:

URGE → TENSION → THEFT → RELIEF → GUILT → REPEATED URGE

But not every act of shoplifting is kleptomania.

Holmes must exclude stealing motivated by:

* financial gain

* genuine need

* anger

* revenge

* delusions or hallucinations

* mania

* conduct disorder

* antisocial personality disorder.

The distinction is crucial because shoplifting describes a behaviour; kleptomania describes the psychopathological mechanism driving it.

The disorder is uncommon in the general population, with an estimated prevalence of approximately 0.3–0.6%, although rates are higher among people arrested for shoplifting. It commonly begins during adolescence, may follow a chronic waxing-and-waning course, and occurs more frequently in women. Comorbidity is extensive, particularly with mood, anxiety, eating, substance use, personality and other impulse-control disorders. OCD is also frequently reported, raising questions about whether kleptomania shares compulsive as well as impulsive mechanisms.

Its neurobiology remains uncertain. Studies suggest possible involvement of impulsivity, executive control, inferior frontal and orbitofrontal circuitry, while serotonin, dopamine, opioid and glutamatergic systems have all been investigated.

Treatment evidence remains limited. SSRIs have produced inconsistent results, whereas naltrexone has some of the strongest pharmacological evidence, including a placebo-controlled trial showing substantially greater symptom remission than placebo. Lithium, topiramate and memantine have also been explored.

Psychological treatment is less well studied, but CBT approaches - including exposure and response prevention - may help patients recognise the urge, tolerate the rising tension and discover that it can decline without stealing.

Holmes therefore does not concentrate on the stolen object.

He concentrates on the seconds before the hand reaches for it.

Because that is where kleptomania begins -

and where treatment must create a different choice.

Key Takeaways

1. Kleptomania Is Not Ordinary Theft

The central feature is:

RECURRENT FAILURE TO RESIST THE IMPULSE TO STEAL

The stolen objects are not needed for:

* personal use

* monetary value.

2. The Diagnostic Cycle Is Characteristic

The typical sequence is:

URGE → TENSION → THEFT → PLEASURE / RELIEF

The relief reinforces the behaviour and helps perpetuate the cycle.

3. The Theft Is Usually Not Premeditated

Unlike calculated theft, there is typically:

* little planning

* little consideration of consequences

* strong immediate impulse.

4. The Object Is Often Relatively Unimportant

The person may:

* hide it

* hoard it

* give it away

* return it.

The psychological reward lies primarily in the act of stealing, not acquisition of the object.

5. The Urge Is Usually Ego-Dystonic

People commonly recognise the behaviour as unwanted and inconsistent with their values.

This can produce profound:

* shame

* guilt

* embarrassment

* depression.

6. Suicide Risk Should Not Be Forgotten

Severe guilt, legal consequences, relationship problems and distress can contribute to:

* depression

* suicidal thoughts or behaviour.

Risk assessment remains important.

7. Motive Is Central to Diagnosis

Kleptomania excludes stealing primarily motivated by:

NEED • PROFIT • ANGER • REVENGE

It also excludes theft occurring because of:

DELUSIONS OR HALLUCINATIONS

8. Shoplifting Does Not Equal Kleptomania

SHOPLIFTING = BEHAVIOUR

KLEPTOMANIA = PSYCHIATRIC SYNDROME

Only a minority of people arrested for shoplifting meet diagnostic criteria for kleptomania.

9. Important Differential Diagnoses

Consider:

* conduct disorder

* manic episodes

* antisocial personality disorder

* psychotic disorders

* ordinary financially motivated theft.

10. Prevalence Is Approximately 0.3–0.6%

Kleptomania appears uncommon in the general population but may be underdiagnosed because people are often ashamed to disclose symptoms.

11. Onset Commonly Occurs in Adolescence

The chapter reports an average onset around:

18–19 YEARS

although symptoms can begin in childhood or adulthood.

12. The Course Is Often Chronic

Symptoms typically:

WAX AND WANE

rather than following a simple single episode.

13. Women Predominate in Clinical Samples

Approximately:

TWO-THIRDS

of individuals with kleptomania are women.

14. Comorbidity Is Extensive

Common associated disorders include:

* compulsive buying

* mood disorders

* anxiety disorders

* eating disorders

* substance use disorders

* personality disorders

* other impulse-control disorders.

15. OCD Is Particularly Interesting

Reported OCD rates in kleptomania vary considerably, reaching high levels in some samples.

This has led to the hypothesis that kleptomania may share features with the:

OBSESSIVE-COMPULSIVE SPECTRUM

16. Impulsivity Is Also Important

Studies have demonstrated increased:

* cognitive impulsivity

* sensation seeking

* overall impulsivity.

Greater impulsivity may contribute to legal consequences.

17. Executive Dysfunction May Increase With Severity

More severe kleptomania has been associated with poorer:

EXECUTIVE FUNCTIONING

even when obvious neuropsychological impairment is absent at group level.

18. Frontal Circuitry May Be Involved

Limited imaging evidence suggests possible abnormalities involving:

* inferior frontal white matter

* orbitofrontal regions

* ventral striatal circuitry.

These remain hypotheses rather than diagnostic findings.

19. There Is No Established Single Neurotransmitter Explanation

Research and treatment studies have implicated:

* serotonin

* dopamine

* endogenous opioid systems

* glutamate.

The evidence remains incomplete.

20. SSRIs Have Mixed Evidence

SSRIs were explored because of similarities between kleptomania and OCD.

However:

RESULTS ARE INCONSISTENT

A controlled trial of escitalopram did not demonstrate clear benefit.

21. Naltrexone Has Stronger Evidence

The opioid antagonist:

NALTREXONE

has reduced:

* urges to steal

* stealing behaviour

* overall kleptomania symptoms.

The chapter describes a placebo-controlled study in which remission occurred in 66% with naltrexone versus 7.7% with placebo.

22. Other Medications Have Been Explored

Preliminary evidence includes:

* lithium

* topiramate

* memantine.

The evidence base remains small.

23. CBT May Help

CBT aims to identify:

* triggers

* thoughts

* urges

* physiological arousal

* consequences.

The person then develops alternative responses to the urge.

24. Exposure and Response Prevention May Be Useful

The therapeutic principle is:

EXPERIENCE THE URGE WITHOUT COMPLETING THE THEFT

This can weaken the learned connection between tension and stealing.

25. Symptoms Can Be Monitored

The chapter describes the:

Kleptomania Symptom Assessment Scale - K-SAS

for assessing changes in:

* urges

* behaviours

* cognitions

during treatment.

26. The Central Diagnostic Question

Holmes asks:

“WHAT WAS THE PERSON TRYING TO OBTAIN?”

If the answer is:

money, property, revenge or practical benefit

think ordinary or instrumental theft.

If the answer is:

relief from an escalating internal urge

consider kleptomania.

27. The Central Behavioural Loop

TRIGGER / URGE

↓

RISING TENSION

↓

FAILURE TO RESIST

↓

THEFT

↓

PLEASURE / RELIEF

↓

GUILT / CONSEQUENCES

↓

URGE RETURNS

Treatment aims to transform this into:

URGE → RECOGNITION → TOLERANCE → NON-STEALING RESPONSE → CONTROL

and subsequent pleasure or relief.

Medlock Holmes enters a vast Neo-Victorian fire investigation chamber where one question dominates the room:

WHY WAS THE FIRE SET?

Pyromania is not simply fire setting, and most people who deliberately start fires do not have pyromania. The diagnosis requires repeated, deliberate and purposeful fire setting accompanied by increasing tension or emotional arousal beforehand and pleasure, gratification or relief during the act or while witnessing its aftermath. Individuals may also show an unusual fascination with fire itself - its equipment, institutions, consequences and the people associated with firefighting.

The motive is crucial.

Pyromania excludes fires set for:

* financial gain

* revenge

* anger

* concealment of another crime

* political or ideological expression

* intimidation

* psychosis

* intoxication

* impaired judgement from another neurological or psychiatric disorder.

This distinguishes pyromania from the much broader behaviour of arson or fire setting.

Holmes also has to distinguish pathological behaviour from ordinary developmental curiosity. Children may experiment with matches or flames without having a psychiatric disorder. In young people, assessment must explore developmental level, motive, recurrence, family environment and broader behavioural disturbance.

Pyromania itself appears to be rare. General fire setting is considerably more common, and most recurrent arsonists do not meet diagnostic criteria for pyromania. The disorder appears more frequently in males and usually begins in adolescence or young adulthood. Its course may be chronic or fluctuate over time.

The neurobiology remains poorly understood. Limited reports suggest possible abnormalities in frontal inhibitory control, cognitive flexibility, serotonin and noradrenaline systems, while dopaminergic vulnerability has also been suggested in isolated cases. These findings remain preliminary rather than established biomarkers.

Treatment evidence is similarly limited. There are no approved medications specifically for pyromania and no controlled pharmacological trials. Case reports describe possible benefit from several medications, but findings are inconsistent.

The strongest practical approach is behavioural and psychological treatment. CBT may help identify the sequence:

TRIGGER → TENSION → FIRE-RELATED THOUGHT → URGE → FIRE SETTING → RELIEF

Treatment then creates alternative responses before the behaviour occurs.

Fire-safety education, relaxation strategies, positive reinforcement, behavioural analysis and structured firesetting programmes may also contribute.

Holmes therefore ends the investigation with a simple principle:

“Do not diagnose the fire. Diagnose the motive, the pattern and the reinforcement.”

Key Takeaways

1. Pyromania Is More Than Fire Setting

The disorder requires:

REPEATED DELIBERATE AND PURPOSEFUL FIRE SETTING

Fire setting alone does not establish the diagnosis.

2. Tension Usually Builds Before the Act

A characteristic sequence is:

TENSION / AROUSAL → FIRE SETTING → PLEASURE OR RELIEF

This resembles the reinforcement pattern seen in some other impulse-control disorders.

3. Fascination With Fire Is Characteristic

Individuals may show unusual interest in:

* fires

* fire equipment

* fire stations

* firefighters

* consequences of fires.

4. Pleasure or Relief Is Important

The person may experience:

* gratification

* pleasure

* emotional release

while setting the fire or observing its aftermath.

5. Motive Determines the Diagnosis

Pyromania excludes fire setting for:

* money

* revenge

* anger

* concealment of crime

* political ideology

* intimidation.

6. Pyromania Is Not the Same as Arson

ARSON = BEHAVIOUR / LEGAL CONCEPT

PYROMANIA = PSYCHIATRIC DISORDER

Most people who commit arson do not have pyromania.

7. Psychosis Excludes the Diagnosis When It Explains the Fire Setting

If a person starts a fire because of:

* delusions

* hallucinations

the behaviour is better explained by the psychotic disorder.

8. Other Important Differential Diagnoses

Consider:

* conduct disorder

* manic episodes

* antisocial personality disorder

* intellectual disability

* major neurocognitive disorder

* substance intoxication

* epilepsy or another medical condition.

9. Childhood Fire Curiosity Is Not Automatically Pathological

Children may experiment with:

* matches

* lighters

* flames

as part of development.

Repeated behaviour, motive and risk must be assessed carefully.

10. Pyromania Appears Rare

The true prevalence is unknown.

General lifetime fire setting is substantially more common than true pyromania.

11. Most Arsonists Do Not Meet Criteria for Pyromania

This is one of the most important clinical distinctions.

Common motives among people who set fires include:

* anger

* revenge

* intoxication.

These motives generally exclude pyromania.

12. Onset Usually Occurs Early

Pyromania most often begins in:

ADOLESCENCE OR YOUNG ADULTHOOD

13. The Course May Be Chronic

Fire-setting behaviour may:

* increase over time

* fluctuate

* remit and recur.

Long-term natural-history evidence remains limited.

14. Comorbidity Is Common

Associated conditions include:

* other impulse-control disorders

* substance use disorders

* gambling disorder

* bipolar disorder

* disruptive behaviour disorders.

15. The Neurobiology Remains Uncertain

Limited evidence suggests possible involvement of:

* frontal inhibitory systems

* executive function

* cognitive flexibility

* serotonin

* noradrenaline

* dopamine.

None is diagnostically established.

16. Frontal Inhibitory Dysfunction Is One Hypothesis

Case reports and neuropsychological studies suggest possible problems with:

* executive function

* attention

* cognitive flexibility.

Evidence remains preliminary.

17. Compulsivity May Matter as Much as Impulsivity

One case described:

COGNITIVE INFLEXIBILITY

without clear abnormalities in impulsivity or decision-making.

Pyromania may therefore contain both impulsive and compulsive features.

18. Dopamine May Influence Vulnerability in Some Individuals

A case involving Parkinson disease described fire-setting behaviour emerging after:

* dopamine agonist treatment

* levodopa.

This remains an isolated observation rather than a general mechanism.

19. There Is No Approved Medication Specifically for Pyromania

No medication has an established regulatory indication for the disorder.

Evidence is largely based on:

CASE REPORTS

20. Reported Medications Have Produced Mixed Results

Case reports have described possible benefit from:

* SSRIs

* lithium

* naltrexone

* topiramate

* valproate

* carbamazepine

* stimulants

* clonazepam

* olanzapine.

Other reports show little or no improvement.

21. CBT Is the Most Promising Psychological Approach

CBT can examine:

* triggers

* thoughts

* emotional arousal

* urges

* consequences

* alternative behaviours.

22. Fire-Safety Education Is Important

Treatment may include explicit education about:

* injury

* property destruction

* legal consequences

* community risk.

23. Behavioural Analysis Can Reveal the Pattern

A useful sequence is:

ANTECEDENT

↓

EMOTION

↓

URGE

↓

FIRE SETTING

↓

RELIEF / GRATIFICATION

↓

CONSEQUENCE

24. Graphing Therapy Can Make the Cycle Visible

The chapter describes visually mapping:

* events

* emotions

* fire-setting episodes

to reveal temporal relationships.

25. Structured Programmes May Reduce Fire-Related Attitudes and Behaviour

Specialist programmes can target:

* fascination with fire

* attitudes towards fire

* anger

* understanding of consequences

* safety awareness.

26. Risk Management Is Essential

Assessment must consider:

* access to ignition sources

* previous fires

* escalation

* deliberate planning

* targets

* intoxication

* suicidality

* danger to others.

27. Suicidality Should Be Assessed

The chapter describes substantial shame in some individuals, with some reporting suicidal thoughts related to inability to stop the behaviour.

28. The Central Diagnostic Question

Holmes asks:

“WHY WAS THE FIRE SET?”

That question separates:

PYROMANIA

from:

REVENGE • PROFIT • PSYCHOSIS • INTOXICATION • CRIME • DEVELOPMENTAL CURIOSITY

29. The Central Behavioural Loop

A useful clinical model is:

FASCINATION / TRIGGER

↓

TENSION

↓

URGE

↓

FIRE SETTING

↓

PLEASURE / RELIEF

↓

REINFORCEMENT

Treatment must interrupt this loop before the fire is set.